{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:48:25Z","timestamp":1787582905403,"version":"build-2736575974"},"reference-count":367,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12072-021-10170-1","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:01:36Z","timestamp":1620086496000},"page":"223-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["The\u00a0Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis"],"prefix":"10.1007","volume":"15","author":[{"given":"Guiqiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8069-9901","authenticated-orcid":false,"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jidong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cumali","family":"Efe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Payawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Gani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Omata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv Kumar","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"issue":"8","key":"10170_CR1","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/jgh.12952","volume":"30","author":"F Yang","year":"2015","unstructured":"Yang F, Wang Q, Bian Z, Ren LL, Jia J, Ma X. Autoimmune hepatitis: east meets west. J Gastroenterol Hepatol 2015;30(8):1230\u20131236","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10170_CR2","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/jgh.14746","volume":"34","author":"T Lv","year":"2019","unstructured":"Lv T, Li M, Zeng N, Zhang J, Li S, Chen S, et al. Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population. J Gastroenterol Hepatol 2019;34(10):1676\u20131684","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10170_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/MCG.0b013e318228b781","volume":"46","author":"RJ Wong","year":"2012","unstructured":"Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. The impact of race\/ethnicity on the clinical epidemiology of autoimmune hepatitis. J Clin Gastroenterol 2012;46(2):155\u2013161","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10170_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s12072-016-9767-9","volume":"10","author":"A Tanaka","year":"2016","unstructured":"Tanaka A, Ma X, Yokosuka O, Weltman M, You H, Amarapurkar DN, et al. Autoimmune liver diseases in the Asia-Pacific region: proceedings of APASL symposium on AIH and PBC 2016. Hepatol Int 2016;10(6):909\u2013915","journal-title":"Hepatol Int"},{"issue":"8","key":"10170_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/hepr.13342","volume":"49","author":"A Tanaka","year":"2019","unstructured":"Tanaka A, Mori M, Matsumoto K, Ohira H, Tazuma S, Takikawa H. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatol Res 2019;49(8):881\u2013889.","journal-title":"Hepatol Res"},{"issue":"8","key":"10170_CR6","doi-asserted-by":"publisher","first-page":"e0182391","DOI":"10.1371\/journal.pone.0182391","volume":"12","author":"BH Kim","year":"2017","unstructured":"Kim BH, Choi HY, Ki M, Kim KA, Jang ES, Jeong SH. Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in south Korea. PLoS ONE 2017;12(8):e0182391","journal-title":"PLoS ONE"},{"issue":"10","key":"10170_CR7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","volume":"25","author":"JH Ngu","year":"2010","unstructured":"Ngu JH, Bechly K, Chapman BA, Burt MJ, Barclay ML, Gearry RB, et al. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol 2010;25(10):1681\u20131686","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10170_CR8","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1111\/liv.14224","volume":"39","author":"KB Valgeirsson","year":"2019","unstructured":"Valgeirsson KB, Hreinsson JP, Bjornsson ES. Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs. Liver Int 2019;39(12):2341\u20132349","journal-title":"Liver Int"},{"key":"10170_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaut.2013.07.004","volume":"46","author":"GF Mells","year":"2013","unstructured":"Mells GF, Kaser A, Karlsen TH. Novel insights into autoimmune liver diseases provided by genome-wide association studies. J Autoimmun 2013;46:41\u201354","journal-title":"J Autoimmun"},{"issue":"10","key":"10170_CR10","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1080\/00365520802130183","volume":"43","author":"M Werner","year":"2008","unstructured":"Werner M, Prytz H, Ohlsson B, Almer S, Bjornsson E, Bergquist A, et al. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol 2008;43(10):1232\u20131240","journal-title":"Scand J Gastroenterol"},{"key":"10170_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jaut.2015.10.006","volume":"66","author":"Q Wang","year":"2016","unstructured":"Wang Q, Yang F, Miao Q, Krawitt EL, Gershwin ME, Ma X. The clinical phenotypes of autoimmune hepatitis: a comprehensive review. J Autoimmun 2016;66:98\u2013107","journal-title":"J Autoimmun"},{"issue":"4","key":"10170_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","author":"EASL","year":"2015","unstructured":"EASL. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol 2015;63(4):971\u20131004","journal-title":"J Hepatol"},{"key":"10170_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","volume":"95","author":"A Floreani","year":"2018","unstructured":"Floreani A, Restrepo-Jimenez P, Secchi MF, De Martin S, Leung PSC, Krawitt E, et al. Etiopathogenesis of autoimmune hepatitis. J Autoimmun 2018;95:133\u2013143","journal-title":"J Autoimmun"},{"issue":"6","key":"10170_CR14","doi-asserted-by":"publisher","first-page":"e100565","DOI":"10.1371\/journal.pone.0100565","volume":"9","author":"T Umemura","year":"2014","unstructured":"Umemura T, Katsuyama Y, Yoshizawa K, Kimura T, Joshita S, Komatsu M, et al. Human leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in Japan. PLoS ONE 2014;9(6):e100565","journal-title":"PLoS ONE"},{"issue":"10","key":"10170_CR15","doi-asserted-by":"publisher","first-page":"e0187325","DOI":"10.1371\/journal.pone.0187325","volume":"12","author":"S Oka","year":"2017","unstructured":"Oka S, Furukawa H, Yasunami M, Kawasaki A, Nakamura H, Nakamura M, et al. HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: the predisposing role of the DR4\/DR8 heterozygous genotype. PLoS ONE 2017;12(10):e0187325","journal-title":"PLoS ONE"},{"key":"10170_CR16","first-page":"967","volume":"51","author":"DN Amarapurkar","year":"2003","unstructured":"Amarapurkar DN, Patel ND, Amarapurkar AD, Kankonkar SR. HLA genotyping in type-I autoimmune hepatitis in western India. J Assoc Physicians India 2003;51:967\u2013969","journal-title":"J Assoc Physicians India"},{"issue":"1","key":"10170_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jceh.2013.12.002","volume":"4","author":"N Kaur","year":"2014","unstructured":"Kaur N, Minz RW, Anand S, Saikia B, Aggarwal R, Das A, et al. HLA DRB1 alleles discriminate the manifestation of autoimmune hepatitis as type 1 or type 2 in north Indian population. J Clin Exp Hepatol 2014;4(1):14\u201318","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"10170_CR18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1572-0241.2005.41053.x","volume":"100","author":"A Hiraide","year":"2005","unstructured":"Hiraide A, Imazeki F, Yokosuka O, Kanda T, Kojima H, Fukai K, et al. Fas polymorphisms influence susceptibility to autoimmune hepatitis. Am J Gastroenterol 2005;100(6):1322\u20131329","journal-title":"Am J Gastroenterol"},{"key":"10170_CR19","doi-asserted-by":"publisher","first-page":"29770","DOI":"10.1038\/srep29770","volume":"6","author":"T Umemura","year":"2016","unstructured":"Umemura T, Joshita S, Yamazaki T, Komatsu M, Katsuyama Y, Yoshizawa K, et al. Genetic association of PTPN22 polymorphisms with autoimmune hepatitis and primary biliary cholangitis in Japan. Sci Rep 2016;6:29770","journal-title":"Sci Rep"},{"issue":"2","key":"10170_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1440-1746.2005.03532.x","volume":"20","author":"L Fan","year":"2005","unstructured":"Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R, et al. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol 2005;20(2):249\u2013255","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10170_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","volume":"147","author":"YS de Boer","year":"2014","unstructured":"de Boer YS, van Gerven NM, Zwiers A, Verwer BJ, van Hoek B, van Erpecum KJ, et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology 2014;147(2):443-452.e5","journal-title":"Gastroenterology"},{"key":"10170_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2015.08.016","volume":"66","author":"GJ Webb","year":"2016","unstructured":"Webb GJ, Hirschfield GM. Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun 2016;66:25\u201339","journal-title":"J Autoimmun"},{"issue":"3","key":"10170_CR23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/0016-5085(92)90041-V","volume":"103","author":"T Seki","year":"1992","unstructured":"Seki T, Ota M, Furuta S, Fukushima H, Kondo T, Hino K, et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992;103(3):1041\u20131047","journal-title":"Gastroenterology"},{"issue":"6","key":"10170_CR24","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","volume":"112","author":"MD Strettell","year":"1997","unstructured":"Strettell MD, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 1997;112(6):2028\u20132035","journal-title":"Gastroenterology"},{"issue":"2","key":"10170_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/hep.510250211","volume":"25","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Strettell MD, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997;25(2):317\u2013323","journal-title":"Hepatology"},{"issue":"6","key":"10170_CR26","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0168-8278(98)80347-4","volume":"28","author":"MN Vazquez-Garcia","year":"1998","unstructured":"Vazquez-Garcia MN, Alaez C, Olivo A, Debaz H, Perez-Luque E, Burguete A, et al. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Hepatol 1998;28(6):985\u2013990","journal-title":"J Hepatol"},{"issue":"7","key":"10170_CR27","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","volume":"94","author":"PL Bittencourt","year":"1999","unstructured":"Bittencourt PL, Goldberg AC, Cancado EL, Porta G, Carrilho FJ, Farias AQ, et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol 1999;94(7):1906\u20131913","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10170_CR28","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3748\/wjg.v11.i12.1862","volume":"11","author":"P Muratori","year":"2005","unstructured":"Muratori P, Czaja AJ, Muratori L, Pappas G, Maccariello S, Cassani F, et al. Genetic distinctions between autoimmune hepatitis in Italy and north America. World J Gastroenterol 2005;11(12):1862\u20131866","journal-title":"World J Gastroenterol"},{"issue":"34","key":"10170_CR29","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.3748\/wjg.v12.i34.5513","volume":"12","author":"A Teufel","year":"2006","unstructured":"Teufel A, Worns M, Weinmann A, Centner C, Piendl A, Lohse AW, et al. Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients. World J Gastroenterol 2006;12(34):5513\u20135516","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10170_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","volume":"45","author":"T Al-Chalabi","year":"2006","unstructured":"Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 2006;45(4):575\u2013583","journal-title":"J Hepatol"},{"issue":"6","key":"10170_CR31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jhep.2006.07.034","volume":"45","author":"I Djilali-Saiah","year":"2006","unstructured":"Djilali-Saiah I, Fakhfakh A, Louafi H, Caillat-Zucman S, Debray D, Alvarez F. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis. J Hepatol 2006;45(6):844\u2013850","journal-title":"J Hepatol"},{"issue":"10","key":"10170_CR32","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/j.1478-3231.2007.01581.x","volume":"27","author":"PF Mdel","year":"2007","unstructured":"Mdel PF, Machado IV, Gil G, Fernandez-Mestre M, Dagher L, Leon RV, et al. Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela. Liver Int 2007;27(10):1409\u20131416","journal-title":"Liver Int"},{"issue":"1","key":"10170_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jhep.2007.08.019","volume":"48","author":"YS Lim","year":"2008","unstructured":"Lim YS, Oh HB, Choi SE, Kwon OJ, Heo YS, Lee HC, et al. Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70\u201374 of the HLA-DRB1 molecule. J Hepatol 2008;48(1):133\u2013139","journal-title":"J Hepatol"},{"issue":"10","key":"10170_CR34","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s10620-015-3708-7","volume":"60","author":"AJ Czaja","year":"2015","unstructured":"Czaja AJ. Transitioning from idiopathic to explainable autoimmune hepatitis. Dig Dis Sci 2015;60(10):2881\u20132900","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10170_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3109\/08830185.2014.921162","volume":"33","author":"U Christen","year":"2014","unstructured":"Christen U, Hintermann E. Pathogen infection as a possible cause for autoimmune hepatitis. Int Rev Immunol 2014;33(4):296\u2013313","journal-title":"Int Rev Immunol"},{"issue":"1","key":"10170_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","volume":"21","author":"NK Gatselis","year":"2015","unstructured":"Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN. Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol 2015;21(1):60\u201383","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10170_CR37","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1007\/s10620-014-3267-3","volume":"59","author":"C Efe","year":"2014","unstructured":"Efe C, Kav T, Aydin C, Cengiz M, Imga NN, Purnak T, et al. Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Dig Dis Sci 2014;59(12):3035\u20133042","journal-title":"Dig Dis Sci"},{"issue":"27","key":"10170_CR38","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1056\/NEJM199912303412707","volume":"341","author":"LJ Albert","year":"1999","unstructured":"Albert LJ, Inman RD. Molecular mimicry and autoimmunity. N Engl J Med 1999;341(27):2068\u20132074","journal-title":"N Engl J Med"},{"issue":"12","key":"10170_CR39","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1136\/gut.2010.235259","volume":"60","author":"D Gleeson","year":"2011","unstructured":"Gleeson D, Heneghan MA, British Society of Gastroenterology. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut 2011;60(12):1611\u20131629","journal-title":"Gut"},{"issue":"4","key":"10170_CR40","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","volume":"56","author":"AJ Czaja","year":"2011","unstructured":"Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011;56(4):958\u2013976.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10170_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1586\/17474124.1.1.113","volume":"1","author":"AJ Czaja","year":"2007","unstructured":"Czaja AJ. Autoimmune hepatitis. Part A: pathogenesis. Expert Rev Gastroenterol Hepatol 2007;1(1):113\u2013128","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10170_CR42","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","volume":"4","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, et al. Autoimmune hepatitis. Nat Rev Dis Primers 2018;4:18017","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10170_CR43","first-page":"5153","volume":"8","author":"R Lin","year":"2015","unstructured":"Lin R, Zhou L, Zhang J, Wang B. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis. Int J Clin Exp Pathol 2015;8(5):5153\u20135160","journal-title":"Int J Clin Exp Pathol"},{"issue":"6380","key":"10170_CR44","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aar7201","volume":"359","author":"SM Vieira","year":"2018","unstructured":"Vieira SM, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 2018;359(6380):1156\u20131161","journal-title":"Science"},{"issue":"3","key":"10170_CR45","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","volume":"69","author":"Y Wei","year":"2020","unstructured":"Wei Y, Li Y, Yan L, Sun C, Miao Q, Wang Q, et al. Alterations of gut microbiome in autoimmune hepatitis. Gut 2020;69(3):569\u2013577","journal-title":"Gut"},{"issue":"1","key":"10170_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","volume":"41","author":"MS Longhi","year":"2004","unstructured":"Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004;41(1):31\u201337","journal-title":"J Hepatol"},{"issue":"1","key":"10170_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","volume":"25","author":"MS Longhi","year":"2005","unstructured":"Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, Cheeseman P, et al. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 2005;25(1):63\u201371","journal-title":"J Autoimmun"},{"issue":"7","key":"10170_CR48","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","volume":"176","author":"MS Longhi","year":"2006","unstructured":"Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, Vergani D, et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006;176(7):4484\u20134491","journal-title":"J Immunol"},{"issue":"3","key":"10170_CR49","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/hep.23792","volume":"52","author":"S Ferri","year":"2010","unstructured":"Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010;52(3):999\u20131007","journal-title":"Hepatology"},{"issue":"4","key":"10170_CR50","doi-asserted-by":"publisher","first-page":"e18909","DOI":"10.1371\/journal.pone.0018909","volume":"6","author":"L Zhao","year":"2011","unstructured":"Zhao L, Tang Y, You Z, Wang Q, Liang S, Han X, et al. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS ONE 2011;6(4):e18909","journal-title":"PLoS ONE"},{"key":"10170_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2014.02.010","volume":"53","author":"H Zhang","year":"2014","unstructured":"Zhang H, Liu Y, Bian Z, Huang S, Han X, You Z, et al. The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury. J Autoimmun 2014;53:55\u201366","journal-title":"J Autoimmun"},{"issue":"1","key":"10170_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hep.20732","volume":"42","author":"JJ Feld","year":"2005","unstructured":"Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005;42(1):53\u201362","journal-title":"Hepatology"},{"issue":"1","key":"10170_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","volume":"35","author":"J Kogan","year":"2002","unstructured":"Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol 2002;35(1):75\u201381","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10170_CR54","first-page":"313","volume":"51","author":"AJ Czaja","year":"2005","unstructured":"Czaja AJ. Diverse manifestations and evolving treatments of autoimmune hepatitis. Minerva Gastroenterol Dietol 2005;51(4):313\u2013333","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"1","key":"10170_CR55","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"EL Krawitt","year":"2006","unstructured":"Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006;354(1):54\u201366","journal-title":"N Engl J Med"},{"issue":"1","key":"10170_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","volume":"139","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 2010;139(1):58-72.e4","journal-title":"Gastroenterology"},{"key":"10170_CR57","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","volume":"41","author":"R Liberal","year":"2013","unstructured":"Liberal R, Grant CR, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: a comprehensive review. J Autoimmun 2013;41:126\u2013139","journal-title":"J Autoimmun"},{"issue":"6","key":"10170_CR58","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1872-034X.2012.01109.x","volume":"43","author":"K Yamamoto","year":"2013","unstructured":"Yamamoto K, Miyake Y, Ohira H, Suzuki Y, Zeniya M, Onji M, et al. Prognosis of autoimmune hepatitis showing acute presentation. Hepatol Res 2013;43(6):630\u2013638","journal-title":"Hepatol Res"},{"issue":"9","key":"10170_CR59","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00535-018-1444-4","volume":"53","author":"S Joshita","year":"2018","unstructured":"Joshita S, Yoshizawa K, Umemura T, Ohira H, Takahashi A, Harada K, et al. Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey. J Gastroenterol 2018;53(9):1079\u20131088","journal-title":"J Gastroenterol"},{"issue":"9","key":"10170_CR60","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s00535-011-0421-y","volume":"46","author":"M Abe","year":"2011","unstructured":"Abe M, Mashiba T, Zeniya M, Yamamoto K, Onji M, Tsubouchi H, et al. Present status of autoimmune hepatitis in Japan: a nationwide survey. J Gastroenterol 2011;46(9):1136\u20131141","journal-title":"J Gastroenterol"},{"issue":"1","key":"10170_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.dld.2009.04.009","volume":"42","author":"Y Miyake","year":"2010","unstructured":"Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, et al. Autoimmune hepatitis with acute presentation in Japan. Dig Liver Dis 2010;42(1):51\u201354","journal-title":"Dig Liver Dis"},{"key":"10170_CR62","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/hep.30205","volume":"70","author":"L Anand","year":"2018","unstructured":"Anand L, Choudhury A, Bihari C, Sharma BC, Kumar M, Maiwall R, et al. Flare of autoimmune hepatitis causing acute on chronic liver failure (ACLF): diagnosis and response to corticosteroid therapy. Hepatology 2019;70(2):587\u2013596. https:\/\/doi.org\/10.1002\/hep.30205","journal-title":"Hepatology"},{"issue":"8","key":"10170_CR63","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1872-034X.2008.00347.x","volume":"38","author":"M Iwai","year":"2008","unstructured":"Iwai M, Jo M, Ishii M, Mori T, Harada Y. Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis. Hepatol Res 2008;38(8):784\u2013789","journal-title":"Hepatol Res"},{"issue":"4","key":"10170_CR64","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2014.06.030","volume":"61","author":"C Weiler-Normann","year":"2014","unstructured":"Weiler-Normann C, Lohse AW. Acute autoimmune hepatitis: many open questions. J Hepatol 2014;61(4):727\u2013729","journal-title":"J Hepatol"},{"issue":"10","key":"10170_CR65","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/lt.25615","volume":"25","author":"GN Dalekos","year":"2019","unstructured":"Dalekos GN, Gatselis NK, Zachou K. Acute severe autoimmune hepatitis: corticosteroids or liver transplantation? Liver Transpl 2019;25(10):1588\u20131589","journal-title":"Liver Transpl"},{"issue":"6","key":"10170_CR66","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51(6):2193\u20132213","journal-title":"Hepatology"},{"issue":"7","key":"10170_CR67","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1872-034X.2008.00329.x","volume":"38","author":"Y Miyake","year":"2008","unstructured":"Miyake Y, Iwasaki Y, Terada R, Nagano T, Kobashi H, Sakaguchi K, et al. A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis. Hepatol Res 2008;38(7):658\u2013663","journal-title":"Hepatol Res"},{"issue":"24","key":"10170_CR68","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.2169\/internalmedicine.51.8372","volume":"51","author":"K Abe","year":"2012","unstructured":"Abe K, Katsushima F, Kanno Y, Takahashi A, Yokokawa J, Ohira H, et al. Clinical features of cirrhosis in Japanese patients with type I autoimmune hepatitis. Intern Med 2012;51(24):3323\u20133328","journal-title":"Intern Med"},{"issue":"8","key":"10170_CR69","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/apt.12470","volume":"38","author":"K Zachou","year":"2013","unstructured":"Zachou K, Muratori P, Koukoulis GK, Granito A, Gatselis N, Fabbri A, et al. Review article: autoimmune hepatitis\u2014current management and challenges. Aliment Pharmacol Ther 2013;38(8):887\u2013913","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10170_CR70","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/hep.22432","volume":"48","author":"AD Yeoman","year":"2008","unstructured":"Yeoman AD, Al-Chalabi T, Karani JB, Quaglia A, Devlin J, Mieli-Vergani G, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening. Hepatology 2008;48(3):863\u2013870","journal-title":"Hepatology"},{"issue":"4","key":"10170_CR71","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PJ Johnson","year":"1993","unstructured":"Johnson PJ, McFarlane IG, OBotP Convenors. Meeting report: International autoimmune hepatitis group. Hepatology 1993;18(4):998\u20131005","journal-title":"Hepatology"},{"issue":"5","key":"10170_CR72","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31(5):929\u2013938","journal-title":"J Hepatol"},{"issue":"1","key":"10170_CR73","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Par\u00e9s A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48(1):169\u2013176","journal-title":"Hepatology"},{"issue":"1 Pt 1","key":"10170_CR74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","author":"The French METAVIR Cooperative Study Group","year":"1994","unstructured":"The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20(1 Pt 1):15\u201320","journal-title":"Hepatology"},{"issue":"2","key":"10170_CR75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00428-011-1115-9","volume":"459","author":"A Rastogi","year":"2011","unstructured":"Rastogi A, Kumar A, Sakhuja P, Bihari C, Gondal R, Hissar S, et al. Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF). Virchows Arch 2011;459(2):121\u2013127","journal-title":"Virchows Arch"},{"issue":"5","key":"10170_CR76","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/hep.27983","volume":"62","author":"MM Kirstein","year":"2015","unstructured":"Kirstein MM, Metzler F, Geiger E, Heinrich E, Hallensleben M, Manns MP, et al. Prediction of short- and long-term outcome in patients with autoimmune hepatitis. Hepatology 2015;62(5):1524\u20131535","journal-title":"Hepatology"},{"issue":"9","key":"10170_CR77","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.dld.2016.06.018","volume":"48","author":"P Muratori","year":"2016","unstructured":"Muratori P, Lalanne C, Bianchi G, Lenzi M, Muratori L. Predictive factors of poor response to therapy in autoimmune hepatitis. Dig Liver Dis 2016;48(9):1078\u20131081","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10170_CR78","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1034\/j.1600-0676.2003.00810.x","volume":"23","author":"AJ Czaja","year":"2003","unstructured":"Czaja AJ, Carpenter HA. Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis. Liver Int 2003;23(2):116\u2013123","journal-title":"Liver Int"},{"issue":"7","key":"10170_CR79","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/ajg.2015.139","volume":"110","author":"HK Dhaliwal","year":"2015","unstructured":"Dhaliwal HK, Hoeroldt BS, Dube AK, McFarlane E, Underwood JC, Karajeh MA, et al. Long-term prognostic significance of persisting histological activity despite biochemical remission in autoimmune hepatitis. Am J Gastroenterol 2015;110(7):993\u2013999","journal-title":"Am J Gastroenterol"},{"key":"10170_CR80","doi-asserted-by":"publisher","unstructured":"FF van den Brand, KS van der Veen, YS de Boer, NM van Gerven, BI Lissenberg-Witte, U Beuers et al. Increased mortality among patients with vs without cirrhosis and autoimmune hepatitis. Clin Gastroenterol Hepatol. 2019;17(5):940\u2013947.e2. https:\/\/doi.org\/10.1016\/j.cgh.2018.09.046.","DOI":"10.1016\/j.cgh.2018.09.046"},{"issue":"3","key":"10170_CR81","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/00365521.2016.1253768","volume":"52","author":"L Puustinen","year":"2017","unstructured":"Puustinen L, Boyd S, Mustonen H, Arkkila P, Arola J, Farkkila M. Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis. Scand J Gastroenterol 2017;52(3):321\u2013327","journal-title":"Scand J Gastroenterol"},{"key":"10170_CR82","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/hepr.12931","volume":"47","author":"K Harada","year":"2017","unstructured":"Harada K, Hiep NC, Ohira H. Challenges and difficulties in pathological diagnosis of autoimmune hepatitis. Hepatol Res 2017;47(10):963\u2013971. https:\/\/doi.org\/10.1111\/hepr.12931","journal-title":"Hepatol Res"},{"issue":"1","key":"10170_CR83","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/lt.25375","volume":"25","author":"G Stirnimann","year":"2019","unstructured":"Stirnimann G, Ebadi M, Czaja AJ, Montano-Loza AJ. Recurrent and de novo autoimmune hepatitis. Liver Transpl 2019;25(1):152\u2013166","journal-title":"Liver Transpl"},{"issue":"4","key":"10170_CR84","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/MPG.0000000000002096","volume":"67","author":"CA Chapin","year":"2018","unstructured":"Chapin CA, Mohammad S, Bass LM, Taylor SA, Kelly S, Alonso EM. Liver biopsy can be safely performed in pediatric acute liver failure to aid in diagnosis and management. J Pediatr Gastroenterol Nutr 2018;67(4):441\u2013445.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10170_CR85","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.dld.2019.01.020","volume":"51","author":"J Stift","year":"2019","unstructured":"Stift J, Semmler G, Walzel C, Mandorfer M, Schwarzer R, Schwabl P, et al. Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information. Dig Liver Dis 2019;51(8):1144\u20131151. https:\/\/doi.org\/10.1016\/j.dld.2019.01.020","journal-title":"Dig Liver Dis"},{"issue":"9","key":"10170_CR86","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2012.146","volume":"9","author":"E Cholongitas","year":"2012","unstructured":"Cholongitas E, Burroughs AK. Liver: transjugular liver biopsy yields high-quality samples. Nat Rev Gastroenterol Hepatol 2012;9(9):491\u2013492","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10170_CR87","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jhep.2007.05.001","volume":"47","author":"G Kalambokis","year":"2007","unstructured":"Kalambokis G, Manousou P, Vibhakorn S, Marelli L, Cholongitas E, Senzolo M, et al. Transjugular liver biopsy\u2013indications, adequacy, quality of specimens, and complications\u2013a systematic review. J Hepatol 2007;47(2):284\u2013294","journal-title":"J Hepatol"},{"issue":"6","key":"10170_CR88","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/17474124.2018.1481388","volume":"12","author":"DJ van Leeuwen","year":"2018","unstructured":"van Leeuwen DJ, Alves V, Balabaud C, Bhathal PS, Bioulac-Sage P, Colombari R, et al. Acute-on-chronic liver failure 2018: a need for (urgent) liver biopsy? Expert Rev Gastroenterol Hepatol 2018;12(6):565\u2013573","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"10170_CR89","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/01.mcg.0000225612.86846.82","volume":"41","author":"U Denzer","year":"2007","unstructured":"Denzer U, Arnoldy A, Kanzler S, Galle PR, Dienes HP, Lohse AW. Prospective randomized comparison of minilaparoscopy and percutaneous liver biopsy: diagnosis of cirrhosis and complications. J Clin Gastroenterol 2007;41(1):103\u2013110","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10170_CR90","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1572-0241.2003.07342.x","volume":"98","author":"U Denzer","year":"2003","unstructured":"Denzer U, Helmreich-Becker I, Galle PR, Lohse AW. Liver assessment and biopsy in patients with marked coagulopathy: value of mini-laparoscopy and control of bleeding. Am J Gastroenterol 2003;98(4):893\u2013900","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10170_CR91","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1055\/s-2007-1001417","volume":"30","author":"I Helmreich-Becker","year":"1998","unstructured":"Helmreich-Becker I, zum Buschenfelde KHM, Lohse AW. Safety and feasibility of a new minimally invasive diagnostic laparoscopy technique. Endoscopy 1998;30(9):756\u2013762","journal-title":"Endoscopy"},{"issue":"26","key":"10170_CR92","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.3748\/wjg.v23.i26.4839","volume":"23","author":"J Zeng","year":"2017","unstructured":"Zeng J, Huang Z-P, Zheng J, Wu T, Zheng R-Q. Non-invasive assessment of liver fibrosis using two-dimensional shear wave elastography in patients with autoimmune liver diseases. World J Gastroenterol 2017;23(26):4839\u20134846","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10170_CR93","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jhep.2017.11.020","volume":"68","author":"J Hartl","year":"2018","unstructured":"Hartl J, Ehlken H, Sebode M, Peiseler M, Krech T, Zenouzi R, et al. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis. J Hepatol 2018;68(4):754\u2013763. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.020","journal-title":"J Hepatol"},{"key":"10170_CR94","doi-asserted-by":"publisher","unstructured":"J Hartl, H Ehlken, M Sebode, M Peiseler, T Krech, R Zenouzi et al. (2017) Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis. J Hepatol. 2018:68(4):754\u2013763. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.020.","DOI":"10.1016\/j.jhep.2017.11.020"},{"issue":"Suppl 1","key":"10170_CR95","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000451011","volume":"92","author":"N Yada","year":"2017","unstructured":"Yada N, Sakurai T, Minami T, Arizumi T, Takita M, Hagiwara S, et al. Influence of liver inflammation on liver stiffness measurement in patients with autoimmune hepatitis evaluation by combinational elastography. Oncology 2017;92(Suppl 1):10\u201315","journal-title":"Oncology"},{"key":"10170_CR96","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.12659\/MSM.907300","volume":"23","author":"L Guo","year":"2017","unstructured":"Guo L, Zheng L, Hu L, Zhou H, Yu L, Liang W. Transient elastography (Fibroscan) performs better than non-invasive markers in assessing liver fibrosis and cirrhosis in autoimmune hepatitis patients. Med Sci Monit 2017;23:5106\u20135112","journal-title":"Med Sci Monit"},{"issue":"3","key":"10170_CR97","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/jgh.13508","volume":"32","author":"Q Xu","year":"2017","unstructured":"Xu Q, Sheng L, Bao H, Chen X, Guo C, Li H, et al. Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis. J Gastroenterol Hepatol 2017;32(3):639\u2013644","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10170_CR98","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jhep.2016.05.023","volume":"65","author":"J Hartl","year":"2016","unstructured":"Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M, et al. Transient elastography in autoimmune hepatitis: timing determines the impact of inflammation and fibrosis. J Hepatol 2016;65(4):769\u2013775","journal-title":"J Hepatol"},{"issue":"6","key":"10170_CR99","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","volume":"105","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993;105(6):1824\u20131832","journal-title":"Gastroenterology"},{"issue":"2","key":"10170_CR100","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","volume":"66","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Baumann U, Czubkowski P, Debray D, Dezsofi A, et al. Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement. J Pediatr Gastroenterol Nutr 2018;66(2):345\u2013360","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10170_CR101","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/jclinpath-2016-204271","volume":"70","author":"HN Canh","year":"2017","unstructured":"Canh HN, Harada K, Ouchi H, Sato Y, Tsuneyama K, Kage M, et al. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J Clin Pathol 2017;70(11):961\u2013969. https:\/\/doi.org\/10.1136\/jclinpath-2016-204271.","journal-title":"J Clin Pathol"},{"issue":"12","key":"10170_CR102","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-008-2254-x","volume":"43","author":"K Fujiwara","year":"2008","unstructured":"Fujiwara K, Fukuda Y, Yokosuka O. Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis. J Gastroenterol 2008;43(12):951\u2013958","journal-title":"J Gastroenterol"},{"issue":"5","key":"10170_CR103","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-2559.2011.03790.x","volume":"58","author":"K Fujiwara","year":"2011","unstructured":"Fujiwara K, Nakano M, Yasui S, Okitsu K, Yonemitsu Y, Yokosuka O. Advanced histology and impaired liver regeneration are associated with disease severity in acute-onset autoimmune hepatitis. Histopathology 2011;58(5):693\u2013704","journal-title":"Histopathology"},{"issue":"6","key":"10170_CR104","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00000478-199506000-00010","volume":"19","author":"LJ Burgart","year":"1995","unstructured":"Burgart LJ, Batts KP, Ludwig J, Nikias GA, Czaja AJ. Recent-onset autoimmune hepatitis. Biopsy findings and clinical correlations. Am J Surg Pathol 1995;19(6):699\u2013708","journal-title":"Am J Surg Pathol"},{"key":"10170_CR105","doi-asserted-by":"publisher","unstructured":"Takahashi A, Arinaga-Hino T, Ohira H, Torimura T, Zeniya M, Abe M et al. Autoimmune hepatitis in Japan: trends in a nationwide survey. J Gastroenterol. 2017;52(5):631\u2013640. https:\/\/doi.org\/10.1007\/s00535-016-1267-0","DOI":"10.1007\/s00535-016-1267-0"},{"issue":"6","key":"10170_CR106","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/hep.1840190629","volume":"19","author":"VJ Desmet","year":"1994","unstructured":"Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19(6):1513\u20131520","journal-title":"Hepatology"},{"issue":"3","key":"10170_CR107","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/his.12558","volume":"66","author":"YS de Boer","year":"2015","unstructured":"de Boer YS, van Nieuwkerk CMJ, Witte BI, Mulder CJJ, Bouma G, Bloemena E. Assessment of the histopathological key features in autoimmune hepatitis. Histopathology 2015;66(3):351\u2013362","journal-title":"Histopathology"},{"key":"10170_CR108","doi-asserted-by":"crossref","unstructured":"K Washington, MP Manns (2018), Autoimmune Hepatitis. Macsween's Pathology of the Liver. AD Burt, LD Ferrell, SG H\u00fcbscher (Ed) 7th ed: Elsevier 491-514","DOI":"10.1016\/B978-0-7020-6697-9.00008-X"},{"issue":"2","key":"10170_CR109","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.path.2018.02.010","volume":"11","author":"RS Gonzalez","year":"2018","unstructured":"Gonzalez RS, Washington K. Primary biliary cholangitis and autoimmune hepatitis. Surg Pathol Clin 2018;11(2):329\u2013349","journal-title":"Surg Pathol Clin"},{"issue":"2","key":"10170_CR110","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0016-5085(93)90432-C","volume":"104","author":"JH Lefkowitch","year":"1993","unstructured":"Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC Jr, et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The hepatitis interventional therapy group. Gastroenterology 1993;104(2):595\u2013603","journal-title":"Gastroenterology"},{"issue":"4","key":"10170_CR111","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/hep.1840150403","volume":"15","author":"N Bach","year":"1992","unstructured":"Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992;15(4):572\u2013577","journal-title":"Hepatology"},{"issue":"3","key":"10170_CR112","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/hep.24481","volume":"54","author":"A Suzuki","year":"2011","unstructured":"Suzuki A, Brunt EM, Kleiner DE, Miquel R, Smyrk TC, Andrade RJ, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011;54(3):931\u2013939","journal-title":"Hepatology"},{"issue":"6","key":"10170_CR113","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00535-015-1131-7","volume":"51","author":"A Hisamochi","year":"2016","unstructured":"Hisamochi A, Kage M, Ide T, Arinaga-Hino T, Amano K, Kuwahara R, et al. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis. J Gastroenterol 2016;51(6):597\u2013607","journal-title":"J Gastroenterol"},{"issue":"6","key":"10170_CR114","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2018.01.033","volume":"68","author":"E De Martin","year":"2018","unstructured":"De Martin E, Michot J-M, Papouin B, Champiat S, Mateus C, Lambotte O, et al. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors. J Hepatol 2018;68(6):1181\u20131190","journal-title":"J Hepatol"},{"issue":"2","key":"10170_CR115","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.26709","volume":"59","author":"DE Kleiner","year":"2014","unstructured":"Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB, et al. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology 2014;59(2):661\u2013670","journal-title":"Hepatology"},{"issue":"1","key":"10170_CR116","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/cei.12558","volume":"180","author":"DM Foureau","year":"2015","unstructured":"Foureau DM, Walling TL, Maddukuri V, Anderson W, Culbreath K, Kleiner DE, et al. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis. Clin Exp Immunol 2015;180(1):40\u201351","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10170_CR117","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1600-0676.1985.tb00219.x","volume":"5","author":"JM Mietkiewski","year":"1985","unstructured":"Mietkiewski JM, Scheuer PJ. Immunoglobulin-containing plasma cells in acute hepatitis. Liver 1985;5(2):84\u201388","journal-title":"Liver"},{"issue":"1","key":"10170_CR118","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","volume":"15","author":"YS de Boer","year":"2017","unstructured":"de Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, et al. Features of autoimmune hepatitis in patients with drug-induced liver injury. Clin Gastroenterol Hepatol 2017;15(1):103-112.e2","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10170_CR119","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/modpathol.2016.267","volume":"30","author":"D Balitzer","year":"2017","unstructured":"Balitzer D, Shafizadeh N, Peters MG, Ferrell LD, Alshak N, Kakar S. Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria. Mod Pathol 2017;30(5):773\u2013783. https:\/\/doi.org\/10.1038\/modpathol.2016.267.","journal-title":"Mod Pathol."},{"issue":"Suppl. 2","key":"10170_CR120","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000440747","volume":"33","author":"DG Tiniakos","year":"2015","unstructured":"Tiniakos DG, Brain JG, Bury YA. Role of histopathology in autoimmune hepatitis. Dig Dis 2015;33(Suppl. 2):53\u201364","journal-title":"Dig Dis"},{"issue":"2\u20133","key":"10170_CR121","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12016-014-8432-0","volume":"48","author":"Q Miao","year":"2015","unstructured":"Miao Q, Bian Z, Tang R, Zhang H, Wang Q, Huang S, et al. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis. Clin Rev Allergy Immunol 2015;48(2\u20133):226\u2013235","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"10170_CR122","first-page":"8703","volume":"10","author":"T Himoto","year":"2017","unstructured":"Himoto T, Kadota K, Fujita K, Nomura T, Morishita A, Yoneyama H, et al. The pathological appearance of hyaline droplets in Kupffer cells is not specific to patients with autoimmune hepatitis. Int J Clin Exp Pathol 2017;10(8):8703\u20138708","journal-title":"Int J Clin Exp Pathol"},{"issue":"8","key":"10170_CR123","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.dld.2017.04.001","volume":"49","author":"JM Lotowska","year":"2017","unstructured":"Lotowska JM, Sobaniec-Lotowska ME, Daniluk U, Lebensztejn DM. Glassy droplet inclusions within the cytoplasm of Kupffer cells: a novel ultrastructural feature for the diagnosis of pediatric autoimmune hepatitis. Dig Liver Dis 2017;49(8):929\u2013933","journal-title":"Dig Liver Dis"},{"key":"10170_CR124","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.humpath.2018.07.014","volume":"82","author":"A Gurung","year":"2018","unstructured":"Gurung A, Assis DN, McCarty TR, Mitchell KA, Boyer JL, Jain D. Histologic features of autoimmune hepatitis: a critical appraisal. Hum Pathol 2018;82:51\u201360","journal-title":"Hum Pathol"},{"issue":"4","key":"10170_CR125","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/MEG.0000000000000545","volume":"28","author":"Y Aizawa","year":"2016","unstructured":"Aizawa Y, Abe H, Sugita T, Seki N, Chuganji Y, Furumoto Y, et al. Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis. Eur J Gastroenterol Hepatol 2016;28(4):391\u2013397","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10170_CR126","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","volume":"2","author":"WR Kessler","year":"2004","unstructured":"Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004;2(7):625\u2013631","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10170_CR127","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4254\/wjh.v4.i9.262","volume":"4","author":"K Abe","year":"2012","unstructured":"Abe K, Kanno Y, Okai K, Katsushima F, Monoe K, Saito H, et al. Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis. World J Hepatol 2012;4(9):262\u2013267","journal-title":"World J Hepatol"},{"issue":"7","key":"10170_CR128","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1478-3231.2011.02524.x","volume":"31","author":"K Fujiwara","year":"2011","unstructured":"Fujiwara K, Yasui S, Tawada A, Fukuda Y, Nakano M, Yokosuka O. Diagnostic value and utility of the simplified international autoimmune hepatitis group criteria in acute-onset autoimmune hepatitis. Liver Int 2011;31(7):1013\u20131020","journal-title":"Liver Int"},{"issue":"3","key":"10170_CR129","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/jcp.2005.029348","volume":"59","author":"H Hofer","year":"2006","unstructured":"Hofer H, Oesterreicher C, Wrba F, Ferenci P, Penner E. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol 2006;59(3):246\u2013249","journal-title":"J Clin Pathol"},{"issue":"10","key":"10170_CR130","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1872-034X.2007.00125.x","volume":"37","author":"Y Miyake","year":"2007","unstructured":"Miyake Y, Iwasaki Y, Terada R, Onishi T, Okamoto R, Takaguchi K, et al. Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis. Hepatol Res 2007;37(10):801\u2013805","journal-title":"Hepatol Res"},{"issue":"2","key":"10170_CR131","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12016-014-8432-0","volume":"48","author":"Q Miao","year":"2015","unstructured":"Miao Q, Bian Z, Tang R, Zhang H, Wang Q, Huang S, et al. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis. Clin Rev Allergy Immunol 2015;48(2):226\u2013235","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10170_CR132","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/gut.41.2.269","volume":"41","author":"HS Te","year":"1997","unstructured":"Te HS, Koukoulis G, Ganger DR. Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis. Gut 1997;41(2):269\u2013271","journal-title":"Gut"},{"issue":"2","key":"10170_CR133","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/gast.1997.v113.pm9247489","volume":"113","author":"DS Pratt","year":"1997","unstructured":"Pratt DS, Fawaz KA, Rabson A, Dellelis R, Kaplan MM. A novel histological lesion in glucocorticoid-responsive chronic hepatitis. Gastroenterology 1997;113(2):664\u2013668","journal-title":"Gastroenterology"},{"issue":"10","key":"10170_CR134","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1111\/j.1572-0241.2002.06055.x","volume":"97","author":"S Ranvir","year":"2002","unstructured":"Ranvir S, Nair S, Farr G, Mason A, Perrillo R. Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature. Am J Gastroenterol 2002;97(10):2679\u20132683","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10170_CR135","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00000478-200404000-00006","volume":"28","author":"J Misdraji","year":"2004","unstructured":"Misdraji J, Thiim M, Graeme-Cook FM. Autoimmune hepatitis with centrilobular necrosis. Am J Surg Pathol 2004;28(4):471\u2013478","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10170_CR136","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.humpath.2007.03.019","volume":"38","author":"Y Zen","year":"2007","unstructured":"Zen Y, Notsumata K, Tanaka N, Nakanuma Y. Hepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis? Hum Pathol 2007;38(11):1669\u20131675","journal-title":"Hum Pathol"},{"issue":"2","key":"10170_CR137","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cgh.2006.10.011","volume":"5","author":"M Abe","year":"2007","unstructured":"Abe M, Onji M, Kawai-Ninomiya K, Michitaka K, Matsuura B, Hiasa Y, et al. Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis. Clin Gastroenterol Hepatol 2007;5(2):255\u2013258","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10170_CR138","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/hepr.12639","volume":"46","author":"K Yoshizawa","year":"2016","unstructured":"Yoshizawa K, Joshita S, Matsumoto A, Umemura T, Tanaka E, Morita S, et al. Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan. Hepatol Res 2016;46(9):878\u2013883","journal-title":"Hepatol Res"},{"issue":"3","key":"10170_CR139","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/jhbp.319","volume":"23","author":"K Fujiwara","year":"2016","unstructured":"Fujiwara K, Fukuda Y, Seza K, Saito M, Yasui S, Nakano M, et al. High level of persistent liver injury is one of clinical characteristics in treatment-na\u00efve acute onset autoimmune hepatitis: experience in a community hospital. J Hepatobiliary Pancreat Sci 2016;23(3):174\u2013180","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"2","key":"10170_CR140","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12072-012-9402-3","volume":"7","author":"K Fujiwara","year":"2013","unstructured":"Fujiwara K, Yasui S, Yokosuka O. Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure. Hepatol Int 2013;7(2):335\u2013346","journal-title":"Hepatol Int"},{"issue":"3","key":"10170_CR141","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1386-6346(02)00274-7","volume":"25","author":"N Okano","year":"2003","unstructured":"Okano N, Yamamoto K, Sakaguchi K, Miyake Y, Shimada N, Hakoda T, et al. Clinicopathological features of acute-onset autoimmune hepatitis. Hepatol Res 2003;25(3):263\u2013270","journal-title":"Hepatol Res"},{"issue":"2","key":"10170_CR142","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1872-034X.2010.00755.x","volume":"41","author":"K Fujiwara","year":"2011","unstructured":"Fujiwara K, Yasui S, Tawada A, Okitsu K, Yonemitsu Y, Chiba T, et al. Autoimmune fulminant liver failure in adults: experience in a Japanese center. Hepatol Res 2011;41(2):133\u2013141","journal-title":"Hepatol Res"},{"issue":"4","key":"10170_CR143","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jhbp.326","volume":"23","author":"K Fujiwara","year":"2016","unstructured":"Fujiwara K, Yasui S, Yonemitsu Y, Arai M, Kanda T, Fukuda Y, et al. Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure. J Hepatobiliary Pancreat Sci 2016;23(4):212\u2013219","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"5","key":"10170_CR144","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0168-8278(94)80251-3","volume":"21","author":"GA Nikias","year":"1994","unstructured":"Nikias GA, Batts KP, Czaja AJ. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol 1994;21(5):866\u2013871","journal-title":"J Hepatol"},{"issue":"3","key":"10170_CR145","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s00535-010-0316-3","volume":"46","author":"S Yasui","year":"2011","unstructured":"Yasui S, Fujiwara K, Yonemitsu Y, Oda S, Nakano M, Yokosuka O. Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol 2011;46(3):378\u2013390","journal-title":"J Gastroenterol"},{"issue":"7","key":"10170_CR146","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/qjmed\/hch072","volume":"97","author":"R Ferrari","year":"2004","unstructured":"Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M, et al. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the \u2018acute\u2019 type. QJM 2004;97(7):407\u2013412","journal-title":"QJM"},{"issue":"10","key":"10170_CR147","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","volume":"49","author":"NM van Gerven","year":"2014","unstructured":"van Gerven NM, Verwer BJ, Witte BI, van Erpecum KJ, van Buuren HR, Maijers I, et al. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol 2014;49(10):1245\u20131254","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10170_CR148","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s12072-016-9727-4","volume":"10","author":"NN Than","year":"2016","unstructured":"Than NN, Ching DK, Hodson J, McDowell P, Mann J, Gupta R, et al. Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients. Hepatol Int 2016;10(4):673\u2013679","journal-title":"Hepatol Int"},{"issue":"5","key":"10170_CR149","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00535-016-1267-0","volume":"52","author":"A Takahashi","year":"2017","unstructured":"Takahashi A, Arinaga-Hino T, Ohira H, Torimura T, Zeniya M, Abe M, et al. Autoimmune hepatitis in Japan: trends in a nationwide survey. J Gastroenterol 2017;52(5):631\u2013640","journal-title":"J Gastroenterol"},{"issue":"3","key":"10170_CR150","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1055\/s-0035-1562942","volume":"35","author":"AD Burt","year":"2015","unstructured":"Burt AD, Lackner C, Tiniakos DG. Diagnosis and assessment of NAFLD: definitions and histopathological classification. Semin Liver Dis 2015;35(3):207\u2013220","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10170_CR151","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s12016-016-8583-2","volume":"52","author":"Z Wang","year":"2017","unstructured":"Wang Z, Sheng L, Yang Y, Yang F, Xiao X, Hua J, et al. The Management of autoimmune hepatitis patients with decompensated cirrhosis: real-world experience and a comprehensive review. Clin Rev Allergy Immunol 2017;52(3):424\u2013435","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10170_CR152","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/1751-2980.12022","volume":"14","author":"QX Wang","year":"2013","unstructured":"Wang QX, Jiang WJ, Miao Q, Xiao X, Zhang HY, Huang SS, et al. Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: a single center experience. J Dig Dis 2013;14(4):175\u2013180","journal-title":"J Dig Dis"},{"issue":"2","key":"10170_CR153","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/gut.51.2.259","volume":"51","author":"M Baeres","year":"2002","unstructured":"Baeres M, Herkel J, Czaja AJ, Wies I, Kanzler S, Cancado EL, et al. Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut 2002;51(2):259\u2013264","journal-title":"Gut"},{"issue":"2","key":"10170_CR154","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/liv.12022","volume":"33","author":"C Efe","year":"2013","unstructured":"Efe C, Ozaslan E, Wahlin S, Purnak T, Muratori L, Quarneti C, et al. Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study. Liver Int 2013;33(2):190\u2013196","journal-title":"Liver Int"},{"issue":"5","key":"10170_CR155","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhepr.2019.09.003","volume":"1","author":"T Umemura","year":"2019","unstructured":"Umemura T, Joshita S, Saito H, Yoshizawa K, Norman GL, Tanaka E, et al. KIR\/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis. JHEP Rep 2019;1(5):353\u2013360","journal-title":"JHEP Rep"},{"issue":"5","key":"10170_CR156","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/MEG.0000000000000580","volume":"28","author":"B Yilmaz","year":"2016","unstructured":"Yilmaz B, Unlu O, Evcen R, Ugurluoglu C. Acute onset seronegative autoimmune hepatitis: are simplified diagnostic criteria sufficient? Eur J Gastroenterol Hepatol 2016;28(5):607\u2013608","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10170_CR157","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","volume":"30","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 1999;30(3):394\u2013401","journal-title":"J Hepatol"},{"issue":"7","key":"10170_CR158","first-page":"445","volume":"7","author":"T Poynard","year":"2011","unstructured":"Poynard T, Ngo Y, Perazzo H, Munteanu M, Lebray P, Moussalli J, et al. Prognostic value of liver fibrosis biomarkers: a meta-analysis. Gastroenterol Hepatol (N Y) 2011;7(7):445\u2013454","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"2","key":"10170_CR159","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38(2):518\u2013526","journal-title":"Hepatology"},{"issue":"10","key":"10170_CR160","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7(10):1104\u20131112","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10170_CR161","doi-asserted-by":"crossref","unstructured":"MS Gungoren, C Efe, T Kav, F Akbiyik (2018) Diagnostic accuracy of enhanced liver fibrosis (ELF) test for significant fibrosis in patients with autoimmune hepatitis. J Lab Precis Med 3(3)","DOI":"10.21037\/jlpm.2018.02.06"},{"issue":"6","key":"10170_CR162","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/MEG.0000000000000355","volume":"27","author":"C Efe","year":"2015","unstructured":"Efe C, Cengiz M, Kahramano\u011flu-Aksoy E, Yilmaz B, \u00d6z\u015feker B, Beyazt Y, et al. Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis. Eur J Gastroenterol Hepatol 2015;27(6):649\u2013654. https:\/\/doi.org\/10.1097\/MEG.0000000000000355","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10170_CR163","doi-asserted-by":"publisher","first-page":"e22922","DOI":"10.1002\/jcla.22922","volume":"33","author":"L Liu","year":"2019","unstructured":"Liu L, Cao J, Zhong Z, Guo Z, Jiang Y, Bai Y, et al. Noninvasive indicators predict advanced liver fibrosis in autoimmune hepatitis patients. J Clin Lab Anal 2019;33(7):e22922","journal-title":"J Clin Lab Anal"},{"issue":"11","key":"10170_CR164","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1097\/MEG.0000000000001437","volume":"31","author":"X Yuan","year":"2019","unstructured":"Yuan X, Duan SZ, Cao J, Gao N, Xu J, Zhang L. Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients. Eur J Gastroenterol Hepatol 2019;31(11):1467\u20131474","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10170_CR165","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cca.2018.07.030","volume":"486","author":"T Zeng","year":"2018","unstructured":"Zeng T, Yu J, Tan L, Wu Y, Tian Y, Wu Q, et al. Noninvasive indices for monitoring disease course in Chinese patients with autoimmune hepatitis. Clin Chim Acta 2018;486:135\u2013141","journal-title":"Clin Chim Acta"},{"issue":"10","key":"10170_CR166","first-page":"782","volume":"19","author":"QX Wang","year":"2011","unstructured":"Wang QX, Shen L, Qiu DK, Bao H, Chen XY, Zeng MD, et al. Validation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis. Zhonghua Gan Zang Bing Za Zhi 2011;19(10):782\u2013784","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"9","key":"10170_CR167","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s00535-008-2225-2","volume":"43","author":"N Obara","year":"2008","unstructured":"Obara N, Ueno Y, Fukushima K, Nakagome Y, Kakazu E, Kimura O, et al. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol 2008;43(9):720\u2013728","journal-title":"J Gastroenterol"},{"issue":"139","key":"10170_CR168","first-page":"670","volume":"62","author":"C Efe","year":"2015","unstructured":"Efe C, Gungoren MS, Ozaslan E, Akbiyik F, Kav T. Acoustic radiation force impulse (ARFI) for fibrosis staging in patients with autoimmune hepatitis. Hepatogastroenterology 2015;62(139):670\u2013672","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"10170_CR169","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5604\/01.3001.0012.7858","volume":"18","author":"RS Goertz","year":"2019","unstructured":"Goertz RS, GaBmann L, Strobel D, Wildner D, Schellhaas B, Neurath MF, et al. Acoustic radiation force impulse (ARFI) elastography in autoimmune and cholestatic liver diseases. Ann Hepatol 2019;18(1):23\u201329","journal-title":"Ann Hepatol"},{"issue":"5","key":"10170_CR170","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3748\/wjg.v23.i5.859","volume":"23","author":"J Wang","year":"2017","unstructured":"Wang J, Malik N, Yin M, Smyrk TC, Czaja AJ, Ehman RL, et al. Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis. World J Gastroenterol 2017;23(5):859\u2013868","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10170_CR171","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/hep.22513","volume":"48","author":"AJ Czaja","year":"2008","unstructured":"Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 2008;48(5):1540\u20131548","journal-title":"Hepatology"},{"issue":"4","key":"10170_CR172","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PJ Johnson","year":"1993","unstructured":"Johnson PJ, McFarlane IG. Meeting report: international autoimmune hepatitis group. Hepatology 1993;18(4):998\u20131005","journal-title":"Hepatology"},{"issue":"3","key":"10170_CR173","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.dld.2009.06.013","volume":"42","author":"Y Miyake","year":"2010","unstructured":"Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, et al. Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the international autoimmune hepatitis group. Dig Liver Dis 2010;42(3):210\u2013215","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10170_CR174","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48(1):169\u2013176","journal-title":"Hepatology"},{"issue":"2","key":"10170_CR175","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/hep.23042","volume":"50","author":"AD Yeoman","year":"2009","unstructured":"Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, Portmann BC, et al. Diagnostic value and utility of the simplified international autoimmune hepatitis group (IAIHG) criteria in acute and chronic liver disease. Hepatology 2009;50(2):538\u2013545","journal-title":"Hepatology"},{"issue":"2","key":"10170_CR176","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jhep.2010.06.032","volume":"54","author":"D Qiu","year":"2011","unstructured":"Qiu D, Wang Q, Wang H, Xie Q, Zang G, Jiang H, et al. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol 2011;54(2):340\u2013347","journal-title":"J Hepatol"},{"issue":"1","key":"10170_CR177","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1440-1746.2012.07292.x","volume":"28","author":"BH Kim","year":"2013","unstructured":"Kim BH, Kim YJ, Jeong SH, Tak WY, Ahn SH, Lee YJ, et al. Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study. J Gastroenterol Hepatol 2013;28(1):128\u2013134","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10170_CR178","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.510280203","volume":"28","author":"O Chazouilleres","year":"1998","unstructured":"Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998;28(2):296\u2013301","journal-title":"Hepatology"},{"key":"10170_CR179","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jaut.2012.10.004","volume":"41","author":"Q Wang","year":"2013","unstructured":"Wang Q, Selmi C, Zhou X, Qiu D, Li Z, Miao Q, et al. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 2013;41:140\u2013145","journal-title":"J Autoimmun"},{"issue":"2","key":"10170_CR180","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51(2):660\u2013678","journal-title":"Hepatology"},{"issue":"4","key":"10170_CR181","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","volume":"33","author":"M Kaya","year":"2000","unstructured":"Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol 2000;33(4):537\u2013542","journal-title":"J Hepatol"},{"issue":"8","key":"10170_CR182","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2017.05.018","volume":"16","author":"M Lian","year":"2017","unstructured":"Lian M, Li B, Xiao X, Yang Y, Jiang P, Yan L, et al. Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC\/AIH and PSC alone. Autoimmun Rev 2017;16(8):875\u2013882","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10170_CR183","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1055\/s-0034-1375959","volume":"34","author":"AS deLemos","year":"2014","unstructured":"deLemos AS, Foureau DM, Jacobs C, Ahrens W, Russo MW, Bonkovsky HL. Drug-induced liver injury with autoimmune features. Semin Liver Dis 2014;34(2):194\u2013204","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10170_CR184","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12016-013-8383-x","volume":"45","author":"K Tsuneyama","year":"2013","unstructured":"Tsuneyama K, Baba H, Kikuchi K, Nishida T, Nomoto K, Hayashi S, et al. Autoimmune features in metabolic liver disease: a single-center experience and review of the literature. Clin Rev Allergy Immunol 2013;45(1):143\u2013148","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10170_CR185","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jgh3.12046","volume":"2","author":"A Takahashi","year":"2018","unstructured":"Takahashi A, Arinaga-Hino T, Ohira H, Abe K, Torimura T, Zeniya M, et al. Non-alcoholic fatty liver disease in patients with autoimmune hepatitis. JGH Open 2018;2(2):54\u201358","journal-title":"JGH Open"},{"issue":"1","key":"10170_CR186","doi-asserted-by":"publisher","first-page":"17452","DOI":"10.1038\/s41598-018-35882-7","volume":"8","author":"R Taubert","year":"2018","unstructured":"Taubert R, Diestelhorst J, Junge N, Kirstein MM, Pischke S, Vogel A, et al. Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis. Sci Rep 2018;8(1):17452","journal-title":"Sci Rep"},{"issue":"1","key":"10170_CR187","doi-asserted-by":"publisher","first-page":"e85330","DOI":"10.1371\/journal.pone.0085330","volume":"9","author":"S Pischke","year":"2014","unstructured":"Pischke S, Gisa A, Suneetha PV, Wiegand SB, Taubert R, Schlue J, et al. Increased HEV seroprevalence in patients with autoimmune hepatitis. PLoS ONE 2014;9(1):e85330","journal-title":"PLoS ONE"},{"issue":"4","key":"10170_CR188","doi-asserted-by":"publisher","first-page":"425","DOI":"10.5578\/mb.67262","volume":"52","author":"AG Sener","year":"2018","unstructured":"Sener AG, Aydin N, Ceylan C, Kirdar S. Investigation of antinuclear antibodies in chronic hepatitis B patients. Mikrobiyol Bul 2018;52(4):425\u2013430","journal-title":"Mikrobiyol Bul"},{"issue":"1","key":"10170_CR189","doi-asserted-by":"publisher","first-page":"e000203","DOI":"10.1136\/bmjgast-2018-000203","volume":"5","author":"AJ Gilman","year":"2018","unstructured":"Gilman AJ, Le AK, Zhao C, Hoang J, Yasukawa LA, Weber SC, et al. Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations. BMJ Open Gastroenterol 2018;5(1):e000203","journal-title":"BMJ Open Gastroenterol"},{"issue":"12","key":"10170_CR190","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/jvh.12302","volume":"21","author":"M Sui","year":"2014","unstructured":"Sui M, Wu R, Hu X, Zhang H, Jiang J, Yang Y, et al. Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population. J Viral Hepat 2014;21(12):925\u2013929","journal-title":"J Viral Hepat"},{"issue":"1","key":"10170_CR191","first-page":"12","volume":"20","author":"S Shantha","year":"2002","unstructured":"Shantha S, Thyagarajan SP, Premavathy RK, Sukumar RG, Mohan KV, Palanisamy KR, et al. Correlation of autoimmune reactivity with hepatitis B and C virus (HBV and HCV) infection in histologically proven chronic liver diseases. Indian J Med Microbiol 2002;20(1):12\u201315","journal-title":"Indian J Med Microbiol"},{"issue":"4","key":"10170_CR192","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3109\/00365521.2013.772231","volume":"48","author":"C Efe","year":"2013","unstructured":"Efe C, Wahlin S, Ozaslan E, Purnak T, Muratori L, Quarneti C, et al. Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B\/C. Scand J Gastroenterol 2013;48(4):504\u2013508","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10170_CR193","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1440-1746.2004.03254.x","volume":"19","author":"S Yener","year":"2004","unstructured":"Yener S, Akarsu M, Karacanci C, Sengul B, Topalak O, Biberoglu K, et al. Wilson\u2019s disease with coexisting autoimmune hepatitis. J Gastroenterol Hepatol 2004;19(1):114\u2013116","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10170_CR194","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jceh.2017.03.006","volume":"7","author":"GK Acharya","year":"2017","unstructured":"Acharya GK, Liao HI, Frunza-Stefan S, Patel R, Khaing M. Autoimmune hepatitis: diagnostic dilemma when it is disguised as iron overload syndrome. J Clin Exp Hepatol 2017;7(3):269\u2013273","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"10170_CR195","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1034\/j.1600-0676.2000.020006482.x","volume":"20","author":"T Hohler","year":"2000","unstructured":"Hohler T, Leininger S, Kohler HH, Schirmacher P, Galle PR. Heterozygosity for the hemochromatosis gene in liver diseases\u2013prevalence and effects on liver histology. Liver 2000;20(6):482\u2013486","journal-title":"Liver"},{"issue":"5","key":"10170_CR196","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/MEG.0000000000000075","volume":"26","author":"C Efe","year":"2014","unstructured":"Efe C, Ozaslan E, Heurgue-Berlot A, Kav T, Masi C, Purnak T, et al. Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol 2014;26(5):532\u2013537","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10170_CR197","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/hep.510230612","volume":"23","author":"KM Boberg","year":"1996","unstructured":"Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 1996;23(6):1369\u20131376","journal-title":"Hepatology"},{"issue":"158","key":"10170_CR198","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","volume":"40","author":"GC Cook","year":"1971","unstructured":"Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971;40(158):159\u2013185","journal-title":"Q J Med"},{"issue":"7806","key":"10170_CR199","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","volume":"1","author":"I Murray-Lyon","year":"1973","unstructured":"Murray-Lyon I, Stern R, Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet 1973;1(7806):735\u2013737","journal-title":"Lancet"},{"issue":"5","key":"10170_CR200","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","volume":"63","author":"R Soloway","year":"1972","unstructured":"Soloway R, Summerskill W, Baggenstoss A, Geall M, Gitnick G, Elveback I, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972;63(5):820\u2013833","journal-title":"Gastroenterology"},{"issue":"11","key":"10170_CR201","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/gut.16.11.876","volume":"16","author":"W Summerskill","year":"1975","unstructured":"Summerskill W, Korman M, Ammon H, Baggenstoss A. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 1975;16(11):876\u2013883","journal-title":"Gut"},{"issue":"2","key":"10170_CR202","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1600-0676.1982.tb00184.x","volume":"2","author":"U Tage-Jensen","year":"1982","unstructured":"Tage-Jensen U, Schlichting P, Aldershvile J, Andersen P, Dietrichson O, Hardt F, et al. Azathioprine versus prednisone in non-alcoholic chronic liver disease (CLD). Relation to a serological classification. Liver 1982;2(2):95\u2013103","journal-title":"Liver"},{"issue":"1","key":"10170_CR203","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","volume":"53","author":"MM Lamers","year":"2010","unstructured":"Lamers MM, van Oijen MG, Pronk M, Drenth JP. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials. J Hepatol 2010;53(1):191\u2013198","journal-title":"J Hepatol"},{"issue":"2","key":"10170_CR204","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0046-8177(72)80072-8","volume":"3","author":"AH Baggenstoss","year":"1972","unstructured":"Baggenstoss AH, Soloway RD, Summerskill WH, Elveback LR, Schoenfield LJ. Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution. Hum Pathol 1972;3(2):183\u2013198","journal-title":"Hum Pathol"},{"issue":"3","key":"10170_CR205","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/hep.1840060302","volume":"6","author":"WG Cooksley","year":"1986","unstructured":"Cooksley WG, Bradbear RA, Robinson W, Harrison M, Halliday JW, Powell LW, et al. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology 1986;6(3):345\u2013348","journal-title":"Hepatology"},{"issue":"2","key":"10170_CR206","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/hep.25658","volume":"56","author":"K Yoshizawa","year":"2012","unstructured":"Yoshizawa K, Matsumoto A, Ichijo T, Umemura T, Joshita S, Komatsu M, et al. Long-term outcome of Japanese patients with type 1 autoimmune hepatitis. Hepatology 2012;56(2):668\u2013676","journal-title":"Hepatology"},{"issue":"1","key":"10170_CR207","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7869\/tg.243","volume":"36","author":"D Amarapurkar","year":"2015","unstructured":"Amarapurkar D, Dharod M, Amarapurkar A. Autoimmune hepatitis in India: single tertiary referral centre experience. Trop Gastroenterol 2015;36(1):36\u201345","journal-title":"Trop Gastroenterol"},{"issue":"5","key":"10170_CR208","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/hep.23924","volume":"52","author":"L Muratori","year":"2010","unstructured":"Muratori L, Muratori P, Lanzoni G, Ferri S, Lenzi M. Application of the 2010 American association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. Hepatology 2010;52(5):1857\u20131857","journal-title":"Hepatology"},{"issue":"8","key":"10170_CR209","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/MCG.0b013e318154af74","volume":"42","author":"S Luth","year":"2008","unstructured":"Luth S, Herkel J, Kanzler S, Frenzel C, Galle PR, Dienes HP, et al. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis. J Clin Gastroenterol 2008;42(8):926\u2013930","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"10170_CR210","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.cgh.2019.11.013","volume":"18","author":"S Pape","year":"2020","unstructured":"Pape S, Gevers TJG, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, et al. Rapid response to treatment of autoimmune hepatitis associated with remission at 6 and 12 months. Clin Gastroenterol Hepatol 2020;18(7):1609-1617.e4","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10170_CR211","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/apt.15111","volume":"49","author":"JK Dyson","year":"2019","unstructured":"Dyson JK, De Martin E, Dalekos GN, Drenth JPH, Herkel J, Hubscher SG, et al. Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the international autoimmune hepatitis group research workshop. Aliment Pharmacol Ther 2019;49(5):528\u2013536","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10170_CR212","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jhep.2013.10.035","volume":"60","author":"C Schramm","year":"2014","unstructured":"Schramm C, Wahl I, Weiler-Normann C, Voigt K, Wiegard C, Glaubke C, et al. Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis. J Hepatol 2014;60(3):618\u2013624","journal-title":"J Hepatol"},{"issue":"6","key":"10170_CR213","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.jhep.2012.07.032","volume":"57","author":"S Sockalingam","year":"2012","unstructured":"Sockalingam S, Blank D, Abdelhamid N, Abbey SE, Hirschfield GM. Identifying opportunities to improve management of autoimmune hepatitis: evaluation of drug adherence and psychosocial factors. J Hepatol 2012;57(6):1299\u20131304","journal-title":"J Hepatol"},{"issue":"6","key":"10170_CR214","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1478-3231.2008.01904.x","volume":"29","author":"AJ Czaja","year":"2009","unstructured":"Czaja AJ. Features and consequences of untreated type 1 autoimmune hepatitis. Liver Int 2009;29(6):816\u2013823","journal-title":"Liver Int"},{"issue":"4","key":"10170_CR215","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jhep.2004.01.009","volume":"40","author":"AJ Czaja","year":"2004","unstructured":"Czaja AJ, Carpenter HA. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 2004;40(4):646\u2013652","journal-title":"J Hepatol"},{"issue":"10","key":"10170_CR216","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","volume":"20","author":"AJ Czaja","year":"2014","unstructured":"Czaja AJ. Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol 2014;20(10):2515\u20132532","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10170_CR217","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/apt.12592","volume":"39","author":"AJ Czaja","year":"2014","unstructured":"Czaja AJ. Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis. Aliment Pharmacol Ther 2014;39(4):385\u2013406","journal-title":"Aliment Pharmacol Ther"},{"issue":"33","key":"10170_CR218","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.3748\/wjg.v23.i33.6030","volume":"23","author":"BT Beretta-Piccoli","year":"2017","unstructured":"Beretta-Piccoli BT, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World J Gastroenterol 2017;23(33):6030\u20136048","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10170_CR219","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00004836-199002000-00013","volume":"12","author":"R Orlando","year":"1990","unstructured":"Orlando R, Lirussi F, Okolicsanyi L. Laparoscopy and liver biopsy: further evidence that the two procedures improve the diagnosis of liver cirrhosis. A retrospective study of 1003 consecutive examinations. J Clin Gastroenterol 1990;12(1):47\u201352","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10170_CR220","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/gut.21.1.78","volume":"21","author":"AP Kirk","year":"1980","unstructured":"Kirk AP, Jain S, Pocock S, Thomas HC, Sherlock S. Late results of the royal free hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. Gut 1980;21(1):78\u201383","journal-title":"Gut"},{"issue":"4","key":"10170_CR221","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jhep.2014.05.021","volume":"61","author":"AD Yeoman","year":"2014","unstructured":"Yeoman AD, Westbrook RH, Zen Y, Bernal W, Al-Chalabi T, Wendon JA, et al. Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome. J Hepatol 2014;61(4):876\u2013882","journal-title":"J Hepatol"},{"issue":"1","key":"10170_CR222","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jhep.2009.02.026","volume":"51","author":"AJ Czaja","year":"2009","unstructured":"Czaja AJ. Rapidity of treatment response and outcome in type 1 autoimmune hepatitis. J Hepatol 2009;51(1):161\u2013167","journal-title":"J Hepatol"},{"issue":"10","key":"10170_CR223","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1007\/s10620-017-4728-2","volume":"62","author":"T Purnak","year":"2017","unstructured":"Purnak T, Efe C, Kav T, Wahlin S, Ozaslan E. Treatment response and outcome with two different prednisolone regimens in autoimmune hepatitis. Dig Dis Sci 2017;62(10):2900\u20132907","journal-title":"Dig Dis Sci"},{"issue":"52","key":"10170_CR224","doi-asserted-by":"publisher","first-page":"e18313","DOI":"10.1097\/MD.0000000000018313","volume":"98","author":"C Zhang","year":"2019","unstructured":"Zhang C, Wu SS, Dong XQ, Wu Z, Zhao H, Wang GQ. The efficacy and safety of different doses of glucocorticoid for autoimmune hepatitis: a systematic review and meta-analysis. Medicine (Baltimore) 2019;98(52):e18313","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10170_CR225","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.cgh.2018.12.035","volume":"17","author":"S Pape","year":"2019","unstructured":"Pape S, Gevers TJG, Belias M, Mustafajev IF, Vrolijk JM, van Hoek B, et al. Predniso(lo)ne dosage and chance of remission in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol 2019;17(10):2068-2075.e2","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10170_CR226","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1111\/liv.14513","volume":"40","author":"S Pape","year":"2020","unstructured":"Pape S, Gevers TJG, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, et al. High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation. Liver Int 2020;40(9):2164\u20132171","journal-title":"Liver Int"},{"issue":"6","key":"10170_CR227","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2217\/pgs.11.32","volume":"12","author":"WG Newman","year":"2011","unstructured":"Newman WG, Payne K, Tricker K, Roberts SA, Fargher E, Pushpakom S, et al. A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. Pharmacogenomics 2011;12(6):815\u2013826","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10170_CR228","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0016-5085(03)01060-6","volume":"125","author":"American Gastroenterological Association","year":"2003","unstructured":"American Gastroenterological Association. American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders. Gastroenterology 2003;125(3):937\u2013940","journal-title":"Gastroenterology"},{"issue":"4","key":"10170_CR229","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/hep.30031","volume":"68","author":"LL Wong","year":"2018","unstructured":"Wong LL, Fisher HF, Stocken DD, Rice S, Khanna A, Heneghan MA, et al. The impact of autoimmune hepatitis and its treatment on health utility. Hepatology 2018;68(4):1487\u20131497","journal-title":"Hepatology"},{"issue":"10","key":"10170_CR230","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/apt.15528","volume":"50","author":"FF van den Brand","year":"2019","unstructured":"van den Brand FF, van der Veen KS, Lissenberg-Witte BI, de Boer YS, van Hoek B, Drenth JPH, et al. Adverse events related to low dose corticosteroids in autoimmune hepatitis. Aliment Pharmacol Ther 2019;50(10):1120\u20131126","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10170_CR231","first-page":"651","volume":"32","author":"RM Weinshilboum","year":"1980","unstructured":"Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980;32(5):651\u2013662","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10170_CR232","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12664-013-0374-6","volume":"33","author":"SK Davavala","year":"2014","unstructured":"Davavala SK, Desai DC, Abraham P, Ashavaid T, Joshi A, Gupta T. Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significance. Indian J Gastroenterol 2014;33(1):41\u201345","journal-title":"Indian J Gastroenterol"},{"issue":"3","key":"10170_CR233","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00008571-200104000-00012","volume":"11","author":"K Kumagai","year":"2001","unstructured":"Kumagai K, Hiyama K, Ishioka S, Sato H, Yamanishi Y, McLeod HL, et al. Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese. Pharmacogenetics 2001;11(3):275\u2013278","journal-title":"Pharmacogenetics"},{"issue":"1","key":"10170_CR234","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000205268","volume":"79","author":"Q Cao","year":"2009","unstructured":"Cao Q, Zhu Q, Shang Y, Gao M, Si J. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease. Digestion 2009;79(1):58\u201363","journal-title":"Digestion"},{"issue":"7","key":"10170_CR235","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/j.1440-1746.2009.05917.x","volume":"24","author":"N Takatsu","year":"2009","unstructured":"Takatsu N, Matsui T, Murakami Y, Ishihara H, Hisabe T, Nagahama T, et al. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease. J Gastroenterol Hepatol 2009;24(7):1258\u20131264","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10170_CR236","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/ng.3060","volume":"46","author":"SK Yang","year":"2014","unstructured":"Yang SK, Hong M, Baek J, Choi H, Zhao W, Jung Y, et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet 2014;46(9):1017\u20131020","journal-title":"Nat Genet"},{"issue":"9","key":"10170_CR237","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1097\/MIB.0000000000001148","volume":"23","author":"K Chao","year":"2017","unstructured":"Chao K, Wang X, Cao Q, Qian J, Wu K, Zhu X, et al. Combined detection of NUDT15 variants could highly predict thiopurine-induced leukopenia in Chinese Patients with inflammatory bowel disease: a multicenter analysis. Inflamm Bowel Dis 2017;23(9):1592\u20131599","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10170_CR238","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/FPC.0000000000000274","volume":"27","author":"HT Kim","year":"2017","unstructured":"Kim HT, Choi R, Won HH, Choe YH, Kang B, Lee K, et al. NUDT15 genotype distributions in the Korean population. Pharmacogenet Genomics 2017;27(5):197\u2013200","journal-title":"Pharmacogenet Genomics"},{"issue":"9","key":"10170_CR239","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2188\/jea.JE20150268","volume":"26","author":"S Kuriyama","year":"2016","unstructured":"Kuriyama S, Yaegashi N, Nagami F, Arai T, Kawaguchi Y, Osumi N, et al. The Tohoku medical megabank project: design and mission. J Epidemiol 2016;26(9):493\u2013511","journal-title":"J Epidemiol"},{"issue":"4","key":"10170_CR240","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0168-8278(02)00214-3","volume":"37","author":"PG Langley","year":"2002","unstructured":"Langley PG, Underhill J, Tredger JM, Norris S, McFarlane IG. Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis. J Hepatol 2002;37(4):441\u2013447","journal-title":"J Hepatol"},{"issue":"3","key":"10170_CR241","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/tpj.2015.43","volume":"16","author":"Y Kakuta","year":"2016","unstructured":"Kakuta Y, Naito T, Onodera M, Kuroha M, Kimura T, Shiga H, et al. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD. Pharmacogenomics J 2016;16(3):280\u2013285","journal-title":"Pharmacogenomics J"},{"issue":"8","key":"10170_CR242","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/MEG.0000000000000648","volume":"28","author":"M Karakoyun","year":"2016","unstructured":"Karakoyun M, Ecevit CO, Kilicoglu E, Aydogdu S, Yagci RV, Ozgenc F. Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience. Eur J Gastroenterol Hepatol 2016;28(8):927\u2013930","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10170_CR243","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2006.05.011","volume":"45","author":"MA Heneghan","year":"2006","unstructured":"Heneghan MA, Allan ML, Bornstein JD, Muir AJ, Tendler DA. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis. J Hepatol 2006;45(4):584\u2013591","journal-title":"J Hepatol"},{"issue":"15","key":"10170_CR244","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJM199510123331502","volume":"333","author":"PJ Johnson","year":"1995","unstructured":"Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995;333(15):958\u2013963","journal-title":"N Engl J Med"},{"issue":"1","key":"10170_CR245","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jhep.2010.12.012","volume":"55","author":"AW Lohse","year":"2011","unstructured":"Lohse AW, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol 2011;55(1):171\u2013182","journal-title":"J Hepatol"},{"issue":"1","key":"10170_CR246","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1053\/gast.1996.v110.pm8536867","volume":"110","author":"DS Pratt","year":"1996","unstructured":"Pratt DS, Flavin DP, Kaplan MM. The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology 1996;110(1):271\u2013274","journal-title":"Gastroenterology"},{"issue":"1","key":"10170_CR247","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ibd.22948","volume":"19","author":"M Akbari","year":"2013","unstructured":"Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis 2013;19(1):15\u201322","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10170_CR248","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases. Hepatology 2020;72(2):671\u2013722","journal-title":"Hepatology"},{"issue":"2","key":"10170_CR249","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.crohns.2010.10.005","volume":"5","author":"S Angelberger","year":"2011","unstructured":"Angelberger S, Reinisch W, Messerschmidt A, Miehsler W, Novacek G, Vogelsang H, et al. Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis 2011;5(2):95\u2013100","journal-title":"J Crohns Colitis"},{"issue":"8","key":"10170_CR250","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/j.1365-2036.2006.03113.x","volume":"24","author":"Y Miyake","year":"2006","unstructured":"Miyake Y, Iwasaki Y, Terada R, Okamaoto R, Ikeda H, Makino Y, et al. Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis. Aliment Pharmacol Ther 2006;24(8):1197\u20131205","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10170_CR251","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1053\/j.gastro.2011.02.065","volume":"140","author":"B Hoeroldt","year":"2011","unstructured":"Hoeroldt B, McFarlane E, Dube A, Basumani P, Karajeh M, Campbell MJ, et al. Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center. Gastroenterology 2011;140(7):1980\u20131989","journal-title":"Gastroenterology"},{"issue":"5","key":"10170_CR252","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/hep.1840030510","volume":"3","author":"JE Hegarty","year":"1983","unstructured":"Hegarty JE, Aria KTN, Portmann B, Eddleston AL, Williams R. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology 1983;3(5):685\u2013689","journal-title":"Hepatology"},{"issue":"1","key":"10170_CR253","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","volume":"58","author":"NM van Gerven","year":"2013","unstructured":"van Gerven NM, Verwer BJ, Witte BI, van Hoek B, Coenraad MJ, van Erpecum KJ, et al. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol 2013;58(1):141\u2013147","journal-title":"J Hepatol"},{"issue":"6","key":"10170_CR254","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s10620-010-1243-0","volume":"55","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ. Late relapse of type 1 autoimmune hepatitis after corticosteroid withdrawal. Dig Dis Sci 2010;55(6):1761\u20131769","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10170_CR255","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jhep.2014.10.018","volume":"62","author":"J Hartl","year":"2015","unstructured":"Hartl J, Ehlken H, Weiler-Normann C, Sebode M, Kreuels B, Pannicke N, et al. Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis. J Hepatol 2015;62(3):642\u2013646","journal-title":"J Hepatol"},{"issue":"5","key":"10170_CR256","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","volume":"102","author":"AJ Montano-Loza","year":"2007","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse. Am J Gastroenterol 2007;102(5):1005\u20131012","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10170_CR257","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1080\/17474124.2020.1822734","volume":"14","author":"C Efe","year":"2020","unstructured":"Efe C, Sim\u015fek C, Bat\u0131bay E, Cal\u0131\u015fkan AR, Wahlin S. Feasibility of telehealth in the management of autoimmune hepatitis before and during the COVID-19 pandemic. Expert Rev Gastroenterol Hepatol 2020;14(12):1215\u20131219","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"10170_CR258","first-page":"221","volume":"8","author":"SW Schalm","year":"1976","unstructured":"Schalm SW, Ammon HV, Summerskill WH. Failure of customary treatment in chronic active liver disease: causes and management. Ann Clin Res 1976;8(3):221\u2013227","journal-title":"Ann Clin Res"},{"issue":"1","key":"10170_CR259","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jhep.2009.10.004","volume":"52","author":"U Hindorf","year":"2010","unstructured":"Hindorf U, Jahed K, Bergquist A, Verbaan H, Prytz H, Wallerstedt S, et al. Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis. J Hepatol 2010;52(1):106\u2013111","journal-title":"J Hepatol"},{"issue":"4","key":"10170_CR260","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/0016-5085(81)90126-8","volume":"80","author":"AJ Czaja","year":"1981","unstructured":"Czaja AJ, Wolf AM, Baggenstoss AH. Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features. Gastroenterology 1981;80(4):687\u2013692","journal-title":"Gastroenterology"},{"issue":"3","key":"10170_CR261","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1517\/14740338.7.3.319","volume":"7","author":"AJ Czaja","year":"2008","unstructured":"Czaja AJ. Safety issues in the management of autoimmune hepatitis. Expert Opin Drug Saf 2008;7(3):319\u2013333","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"10170_CR262","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","volume":"103","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Oo YH, Schramm C, Denzer U, Buggisch P, Wiegard C, et al. Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am J Gastroenterol 2008;103(12):3063\u20133070","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10170_CR263","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1517\/14656566.2011.524206","volume":"12","author":"D Vergani","year":"2011","unstructured":"Vergani D, Mieli-Vergani G. Pharmacological management of autoimmune hepatitis. Expert Opin Pharmacother 2011;12(4):607\u2013613","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10170_CR264","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1053\/jhep.2002.32485","volume":"35","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Menon KV, Carpenter HA. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis. Hepatology 2002;35(4):890\u2013897","journal-title":"Hepatology"},{"issue":"1","key":"10170_CR265","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/hep.24337","volume":"54","author":"JC Duclos-Vallee","year":"2011","unstructured":"Duclos-Vallee JC, Ichai P, Samuel D. Autoimmune acute liver failure. Hepatology 2011;54(1):372\u2013373 (author reply 373)","journal-title":"Hepatology"},{"issue":"2","key":"10170_CR266","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jhep.2016.03.023","volume":"65","author":"R Moenne-Loccoz","year":"2016","unstructured":"Moenne-Loccoz R, Severac F, Baumert TF, Habersetzer F. Usefulness of corticosteroids as first-line therapy in patients with acute severe autoimmune hepatitis. J Hepatol 2016;65(2):444\u2013446","journal-title":"J Hepatol"},{"issue":"23","key":"10170_CR267","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.3748\/wjg.v20.i23.7473","volume":"20","author":"B Zhu","year":"2014","unstructured":"Zhu B, You SL, Wan ZH, Liu HL, Rong YH, Zang H, et al. Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure. World J Gastroenterol 2014;20(23):7473\u20137479","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10170_CR268","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/lt.21036","volume":"13","author":"P Ichai","year":"2007","unstructured":"Ichai P, Duclos-Vallee JC, Guettier C, Hamida SB, Antonini T, Delvart V, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl 2007;13(7):996\u20131003","journal-title":"Liver Transpl"},{"issue":"7","key":"10170_CR269","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/lt.21088","volume":"13","author":"AJ Czaja","year":"2007","unstructured":"Czaja AJ. Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation. Liver Transpl 2007;13(7):953\u2013955","journal-title":"Liver Transpl"},{"issue":"9","key":"10170_CR270","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/j.1365-2036.2006.02894.x","volume":"23","author":"Y Miyake","year":"2006","unstructured":"Miyake Y, Iwasaki Y, Terada R, Onishi T, Okamoto R, Sakai N, et al. Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases. Aliment Pharmacol Ther 2006;23(9):1347\u20131353","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10170_CR271","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/hep.24141","volume":"53","author":"AD Yeoman","year":"2011","unstructured":"Yeoman AD, Westbrook RH, Zen Y, Maninchedda P, Portmann BC, Devlin J, et al. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. Hepatology 2011;53(3):926\u2013934","journal-title":"Hepatology"},{"issue":"20","key":"10170_CR272","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.4103\/0366-6999.191760","volume":"129","author":"YN Li","year":"2016","unstructured":"Li YN, Ma H, Zhou L, Zhang J, Guo LP, Li SQ, et al. Autoimmune hepatitis-related cirrhosis: clinical features and effectiveness of immunosuppressive treatment in Chinese patients. Chin Med J (Engl) 2016;129(20):2434\u20132440","journal-title":"Chin Med J (Engl)"},{"key":"10170_CR273","doi-asserted-by":"publisher","unstructured":"Ng TL et al. Immunosuppresive therapy in autoimmune hepatitis in Hong Kong Chinese: 10-year follow-up of a cohort. Hepatol Int 2009;(Suppl):86\u2013220. https:\/\/doi.org\/10.1007\/s12072-009-9123-4","DOI":"10.1007\/s12072-009-9123-4"},{"issue":"1","key":"10170_CR274","doi-asserted-by":"publisher","first-page":"48","DOI":"10.14218\/JCTH.2017.00032","volume":"6","author":"QX Wang","year":"2018","unstructured":"Wang QX, Yan L, Ma X. Autoimmune hepatitis in the Asia\u2013Pacific area. J Clin Transl Hepatol 2018;6(1):48\u201356","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"10170_CR275","first-page":"138","volume":"62","author":"JC Soares","year":"2016","unstructured":"Soares JC, Borgonovo A, Maggi DC, Pasinato AP, Ramos FG, Dantas-Correa EB, et al. Liver dysfunction and fibrosis as predictors of biochemical response to autoimmune hepatitis treatment. Minerva Gastroenterol Dietol 2016;62(2):138\u2013147","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"5","key":"10170_CR276","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.autrev.2011.09.006","volume":"11","author":"C Efe","year":"2012","unstructured":"Efe C, Ozaslan E, Kav T, Purnak T, Shorbagi A, Ozkayar O, et al. Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome. Autoimmun Rev 2012;11(5):330\u2013334","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10170_CR277","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","volume":"15","author":"A Tansel","year":"2017","unstructured":"Tansel A, Katz LH, El-Serag HB, Thrift AP, Parepally M, Shakhatreh MH, et al. Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2017;15(8):1207-1217.e4","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2\u20133","key":"10170_CR278","doi-asserted-by":"publisher","first-page":"J239","DOI":"10.1016\/j.jaut.2011.12.002","volume":"38","author":"RH Westbrook","year":"2012","unstructured":"Westbrook RH, Yeoman AD, Kriese S, Heneghan MA. Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun 2012;38(2\u20133):J239\u2013J244","journal-title":"J Autoimmun"},{"issue":"4","key":"10170_CR279","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/MCG.0b013e318176b8c5","volume":"43","author":"DR Terrabuio","year":"2009","unstructured":"Terrabuio DR, Abrantes-Lemos CP, Carrilho FJ, Can\u00e7ado EL. Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes. J Clin Gastroenterol 2009;43(4):350\u2013356","journal-title":"J Clin Gastroenterol"},{"key":"10170_CR280","unstructured":"CDC (2017) National birth defects prevention study (NBDPS). https:\/\/www.cdc.gov\/ncbddd\/birthdefects\/nbdps.html. Accessed 26 Oct 2020"},{"issue":"12","key":"10170_CR281","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1111\/j.1572-0241.2002.07124.x","volume":"97","author":"E Buchel","year":"2002","unstructured":"Buchel E, Van Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 2002;97(12):3160\u20133165","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10170_CR282","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/jhep.2001.22131","volume":"33","author":"GV Gregorio","year":"2001","unstructured":"Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, et al. Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001;33(3):544\u2013553","journal-title":"Hepatology"},{"issue":"3","key":"10170_CR283","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/hep.510250308","volume":"25","author":"GV Gregorio","year":"1997","unstructured":"Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25(3):541\u2013547","journal-title":"Hepatology"},{"issue":"4","key":"10170_CR284","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00005176-199311000-00007","volume":"17","author":"G Maggiore","year":"1993","unstructured":"Maggiore G, Veber F, Bernard O, Hadchouel M, Homberg JC, Alvarez F, et al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr 1993;17(4):376\u2013381","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10170_CR285","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/j.1572-0241.2001.03782.x","volume":"96","author":"C Schramm","year":"2001","unstructured":"Schramm C, Kanzler S, zum Buschenfelde KH, Galle PR, Lohse AW. Autoimmune hepatitis in the elderly. Am J Gastroenterol 2001;96(5):1587\u20131591","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10170_CR286","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40266-018-0556-0","volume":"35","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Gawrieh S. Autoimmune hepatitis in the elderly: diagnosis and pharmacologic management. Drugs Aging 2018;35(7):589\u2013602","journal-title":"Drugs Aging"},{"issue":"2","key":"10170_CR287","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MEG.0000000000001019","volume":"30","author":"M De Lemos-Bonotto","year":"2018","unstructured":"De Lemos-Bonotto M, Valle-Tovo C, Costabeber AM, Mattos AA, Azeredo-da-Silva ALF. A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment. Eur J Gastroenterol Hepatol 2018;30(2):212\u2013216","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10170_CR288","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1155\/2008\/509459","volume":"22","author":"I Zandieh","year":"2008","unstructured":"Zandieh I, Krygier D, Wong V, Howard J, Worobetz L, Minuk G, et al. The use of budesonide in the treatment of autoimmune hepatitis in Canada. Can J Gastroenterol 2008;22(4):388\u2013392","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"10170_CR289","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1053\/jhep.2003.50266","volume":"38","author":"W Hempfling","year":"2003","unstructured":"Hempfling W, Grunhage F, Dilger K, Reichel C, Beuers U, Sauerbruch T. Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis. Hepatology 2003;38(1):196\u2013202","journal-title":"Hepatology"},{"issue":"9","key":"10170_CR290","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3748\/wjg.v12.i9.1362","volume":"12","author":"A Csepregi","year":"2006","unstructured":"Csepregi A, Rocken C, Treiber G, Malfertheiner P. Budesonide induces complete remission in autoimmune hepatitis. World J Gastroenterol 2006;12(9):1362\u20131366","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10170_CR291","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","volume":"139","author":"MP Manns","year":"2010","unstructured":"Manns MP, Woynarowski M, Kreisel W, Lurie Y, Rust C, Zuckerman E, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology 2010;139(4):1198\u20131206","journal-title":"Gastroenterology"},{"issue":"3","key":"10170_CR292","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1586\/egh.09.15","volume":"3","author":"AJ Czaja","year":"2009","unstructured":"Czaja AJ. Current and future treatments of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol 2009;3(3):269\u2013291","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"29","key":"10170_CR293","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.2174\/138161211798157568","volume":"17","author":"AJ Czaja","year":"2011","unstructured":"Czaja AJ. Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis. Curr Pharm Des 2011;17(29):3120\u20133140","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10170_CR294","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1159\/000492204","volume":"12","author":"F De Maeyer","year":"2018","unstructured":"De Maeyer F, Lapauw B, Hoorens A, Geerts A, Van Vlierberghe H, Verhelst X. Secondary adrenal insufficiency after treatment with budesonide for autoimmune hepatitis. Case Rep Gastroenterol 2018;12(3):597\u2013601","journal-title":"Case Rep Gastroenterol"},{"issue":"6","key":"10170_CR295","first-page":"4838","volume":"15","author":"FB Lu","year":"2018","unstructured":"Lu FB, Hu ED, Xu LM, Hu YB, Chen L, Wu JL, et al. Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis: a systematic review and network meta-analysis. Exp Ther Med 2018;15(6):4838\u20134850","journal-title":"Exp Ther Med"},{"issue":"5","key":"10170_CR296","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1053\/gast.2000.0010000001","volume":"119","author":"AJ Czaja","year":"2000","unstructured":"Czaja AJ, Lindor KD. Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis. Gastroenterology 2000;119(5):1312\u20131316","journal-title":"Gastroenterology"},{"issue":"10","key":"10170_CR297","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/apt.13584","volume":"43","author":"K Zachou","year":"2016","unstructured":"Zachou K, Gatselis NK, Arvaniti P, Gabeta S, Rigopoulou EI, Koukoulis GK, et al. A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis. Aliment Pharmacol Ther 2016;43(10):1035\u20131047","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10170_CR298","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/gut.50.5.713","volume":"50","author":"T Zolfino","year":"2002","unstructured":"Zolfino T, Heneghan MA, Norris S, Harrison PM, Portmann BC, McFarlane IG. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut 2002;50(5):713\u2013717","journal-title":"Gut"},{"issue":"4","key":"10170_CR299","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","volume":"25","author":"N Chatur","year":"2005","unstructured":"Chatur N, Ramji A, Bain VG, Ma MM, Marotta PJ, Ghent CN, et al. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Liver Int 2005;25(4):723\u2013727","journal-title":"Liver Int"},{"issue":"3","key":"10170_CR300","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jceh.2014.05.003","volume":"4","author":"D Jothimani","year":"2014","unstructured":"Jothimani D, Cramp ME, Cross TJ. Role of mycophenolate mofetil for the treatment of autoimmune hepatitis-an observational study. J Clin Exp Hepatol 2014;4(3):221\u2013225","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"10170_CR301","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","volume":"55","author":"K Zachou","year":"2011","unstructured":"Zachou K, Gatselis N, Papadamou G, Rigopoulou EI, Dalekos GN. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients. J Hepatol 2011;55(3):636\u2013646","journal-title":"J Hepatol"},{"issue":"2","key":"10170_CR302","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.dld.2018.10.004","volume":"51","author":"G Giannakopoulos","year":"2019","unstructured":"Giannakopoulos G, Verbaan H, Friis-Liby IL, Sangfelt P, Nyhlin N, Almer S. Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine. Dig Liver Dis 2019;51(2):253\u2013257","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10170_CR303","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cgh.2017.09.063","volume":"16","author":"SK Roberts","year":"2018","unstructured":"Roberts SK, Lim R, Strasser S, Nicoll A, Gazzola A, Mitchell J, et al. Efficacy and safety of mycophenolate mofetil in patients with autoimmune hepatitis and suboptimal outcomes after standard therapy. Clin Gastroenterol Hepatol 2018;16(2):268\u2013277","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10170_CR304","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/j.cgh.2017.06.001","volume":"15","author":"C Efe","year":"2017","unstructured":"Efe C, Hagstrom H, Ytting H, Bhanji RA, Muller NF, Wang Q, et al. Efficacy and safety of mycophenolate mofetil and tacrolimus as second-line therapy for patients with autoimmune hepatitis. Clin Gastroenterol Hepatol 2017;15(12):1950-1956.e1","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10170_CR305","first-page":"193","volume":"5","author":"S Nasseri-Moghaddam","year":"2013","unstructured":"Nasseri-Moghaddam S, Nikfam S, Karimian S, Khashayar P, Malekzadeh R. Cyclosporine-A versus prednisolone for induction of remission in auto-immune hepatitis: interim analysis report of a randomized controlled trial. Middle East J Dig Dis 2013;5(4):193\u2013200","journal-title":"Middle East J Dig Dis"},{"key":"10170_CR306","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00365521.2018.1551498","volume":"54","author":"M Hanouneh","year":"2019","unstructured":"Hanouneh M, Ritchie MM, Ascha M, Ascha MS, Chedid A, Sanguankeo A, et al. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis. Scand J Gastroenterol 2019;54(1):76\u201380. https:\/\/doi.org\/10.1080\/00365521.2018.1551498.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10170_CR307","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3109\/00365521.2015.1095351","volume":"51","author":"NN Than","year":"2016","unstructured":"Than NN, Wiegard C, Weiler-Normann C, Fussel K, Mann J, Hodson J, et al. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on tacrolimus therapy. Scand J Gastroenterol 2016;51(3):329\u2013336","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10170_CR308","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.cgh.2015.09.037","volume":"14","author":"S Hubener","year":"2016","unstructured":"Hubener S, Oo YH, Than NN, Hubener P, Weiler-Normann C, Lohse AW, et al. Efficacy of 6-mercaptopurine as second-line treatment for patients with autoimmune hepatitis and azathioprine intolerance. Clin Gastroenterol Hepatol 2016;14(3):445\u2013453","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10170_CR309","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00042737-200504000-00012","volume":"17","author":"NK de Boer","year":"2005","unstructured":"de Boer NK, van Nieuwkerk CM, Pages MNA, de Boer SY, Derijks LJ, Mulder CJ. Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine. Eur J Gastroenterol Hepatol 2005;17(4):457\u2013461","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10170_CR310","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ctrv.2016.11.015","volume":"53","author":"F Pavanello","year":"2017","unstructured":"Pavanello F, Zucca E, Ghielmini M. Rituximab: 13 open questions after 20 years of clinical use. Cancer Treat Rev 2017;53:38\u201346","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10170_CR311","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","volume":"58","author":"C Weiler-Normann","year":"2013","unstructured":"Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N, et al. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. J Hepatol 2013;58(3):529\u2013534","journal-title":"J Hepatol"},{"issue":"3","key":"10170_CR312","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.autrev.2012.03.010","volume":"12","author":"C Efe","year":"2013","unstructured":"Efe C. Drug induced autoimmune hepatitis and TNF-\u03b1 blocking agents: is there a real relationship? Autoimmun Rev 2013;12(3):337\u2013339","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10170_CR313","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","volume":"5","author":"N Kerkar","year":"2005","unstructured":"Kerkar N, Dugan C, Rumbo C, Morotti RA, Gondolesi G, Shneider BL, et al. Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transplant 2005;5(5):1085\u20131089","journal-title":"Am J Transplant"},{"issue":"11","key":"10170_CR314","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.amjmed.2014.06.016","volume":"127","author":"H Chatrath","year":"2014","unstructured":"Chatrath H, Allen L, Boyer TD. Use of sirolimus in the treatment of refractory autoimmune hepatitis. Am J Med 2014;127(11):1128\u20131131","journal-title":"Am J Med"},{"issue":"7","key":"10170_CR315","first-page":"571","volume":"35","author":"S Kanzler","year":"1997","unstructured":"Kanzler S, Gerken G, Dienes HP, zum Buschenfelde KHM, Lohse AW. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis\u2013report of three cases. Z Gastroenterol 1997;35(7):571\u2013578","journal-title":"Z Gastroenterol"},{"issue":"6","key":"10170_CR316","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S0168-8278(98)80128-1","volume":"29","author":"KW Burak","year":"1998","unstructured":"Burak KW, Urbanski SJ, Swain MG. Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate. J Hepatol 1998;29(6):990\u2013993","journal-title":"J Hepatol"},{"issue":"7","key":"10170_CR317","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/apt.14939","volume":"48","author":"FF van den Brand","year":"2018","unstructured":"van den Brand FF, van Nieuwkerk CMJ, Verwer BJ, de Boer YS, de Boer NKH, Mulder CJJ, et al. Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands. Aliment Pharmacol Ther 2018;48(7):761\u2013767","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10170_CR318","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1155\/2013\/512624","volume":"27","author":"KW Burak","year":"2013","unstructured":"Burak KW, Swain MG, Santodomingo-Garzon T, Lee SS, Urbanski SJ, Aspinall AI, et al. Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy. Can J Gastroenterol 2013;27(5):273\u2013280","journal-title":"Can J Gastroenterol"},{"issue":"3","key":"10170_CR319","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","volume":"57","author":"R Adam","year":"2012","unstructured":"Adam R, Karam V, Delvart V, O\u2019Grady J, Mirza D, Klempnauer J, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European liver transplant registry (ELTR). J Hepatol 2012;57(3):675\u2013688","journal-title":"J Hepatol"},{"issue":"5","key":"10170_CR320","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","volume":"95","author":"AK Singal","year":"2013","unstructured":"Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation 2013;95(5):755\u2013760","journal-title":"Transplantation"},{"issue":"2\u20133","key":"10170_CR321","first-page":"134","volume":"52","author":"TJLT Society","year":"2015","unstructured":"TJLT Society. Liver transplantation in Japan- registry by the Japanese liver transplantation society- [in Japanese]. Ishoku 2015;52(2\u20133):134\u2013147","journal-title":"Ishoku"},{"issue":"2","key":"10170_CR322","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/jhep.2000.9077","volume":"32","author":"G Ayata","year":"2000","unstructured":"Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, et al. Liver transplantation for autoimmune hepatitis: a long-term pathologic study. Hepatology 2000;32(2):185\u2013192","journal-title":"Hepatology"},{"issue":"9","key":"10170_CR323","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/lt.21525","volume":"14","author":"J Campsen","year":"2008","unstructured":"Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, et al. Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal. Liver Transpl 2008;14(9):1281\u20131286","journal-title":"Liver Transpl"},{"issue":"6","key":"10170_CR324","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/gut.52.6.893","volume":"52","author":"JC Duclos-Vallee","year":"2003","unstructured":"Duclos-Vallee JC, Sebagh M, Rifai K, Johanet C, Ballot E, Guettier C, et al. A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut 2003;52(6):893\u2013897","journal-title":"Gut"},{"issue":"4","key":"10170_CR325","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1053\/jlts.2001.21449","volume":"7","author":"A Gonzalez-Koch","year":"2001","unstructured":"Gonzalez-Koch A, Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, et al. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl 2001;7(4):302\u2013310","journal-title":"Liver Transpl"},{"issue":"1","key":"10170_CR326","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/lt.24323","volume":"22","author":"TL Krishnamoorthy","year":"2016","unstructured":"Krishnamoorthy TL, Miezynska-Kurtycz J, Hodson J, Gunson BK, Neuberger J, Milkiewicz P, et al. Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease. Liver Transpl 2016;22(1):34\u201341","journal-title":"Liver Transpl"},{"issue":"2","key":"10170_CR327","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","volume":"68","author":"P Milkiewicz","year":"1999","unstructured":"Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999;68(2):253\u2013256","journal-title":"Transplantation"},{"issue":"6","key":"10170_CR328","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/jlts.2002.32981","volume":"8","author":"EP Molmenti","year":"2002","unstructured":"Molmenti EP, Netto GJ, Murray NG, Smith DM, Molmenti H, Crippin JS, et al. Incidence and recurrence of autoimmune\/alloimmune hepatitis in liver transplant recipients. Liver Transpl 2002;8(6):519\u2013526","journal-title":"Liver Transpl"},{"issue":"10","key":"10170_CR329","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/lt.21796","volume":"15","author":"AJ Montano-Loza","year":"2009","unstructured":"Montano-Loza AJ, Mason AL, Ma M, Bastiampillai RJ, Bain VG, Tandon P. Risk factors for recurrence of autoimmune hepatitis after liver transplantation. Liver Transpl 2009;15(10):1254\u20131261","journal-title":"Liver Transpl"},{"issue":"12","key":"10170_CR330","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","volume":"66","author":"E Prados","year":"1998","unstructured":"Prados E, Cuervas-Mons V, de la Mata M, Fraga E, Rimola A, Prieto M, et al. Outcome of autoimmune hepatitis after liver transplantation. Transplantation 1998;66(12):1645\u20131650","journal-title":"Transplantation"},{"issue":"1","key":"10170_CR331","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","volume":"30","author":"V Ratziu","year":"1999","unstructured":"Ratziu V, Samuel D, Sebagh M, Farges O, Saliba F, Ichai P, et al. Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol 1999;30(1):131\u2013141","journal-title":"J Hepatol"},{"issue":"4 Pt 1","key":"10170_CR332","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/jhep.2000.16666","volume":"32","author":"DJ Reich","year":"2000","unstructured":"Reich DJ, Fiel I, Guarrera JV, Emre S, Guy SR, Schwartz ME, et al. Liver transplantation for autoimmune hepatitis. Hepatology 2000;32(4 Pt 1):693\u2013700","journal-title":"Hepatology"},{"issue":"4","key":"10170_CR333","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/apt.13894","volume":"45","author":"AJ Montano-Loza","year":"2017","unstructured":"Montano-Loza AJ, Bhanji RA, Wasilenko S, Mason AL. Systematic review: recurrent autoimmune liver diseases after liver transplantation. Aliment Pharmacol Ther 2017;45(4):485\u2013500","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10170_CR334","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bpg.2017.04.004","volume":"31","author":"T Visseren","year":"2017","unstructured":"Visseren T, Murad SD. Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation. Best Pract Res Clin Gastroenterol 2017;31(2):187\u2013198","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10170_CR335","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg P, Bianchi F, Bianchi L, Burroughs A, Cancado E, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929\u2013938","journal-title":"J Hepatol"},{"issue":"3","key":"10170_CR336","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/hep.22435","volume":"48","author":"V Balan","year":"2008","unstructured":"Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, et al. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the national institute of diabetes and digestive and kidney diseases liver transplantation database. Hepatology 2008;48(3):878\u2013888","journal-title":"Hepatology"},{"key":"10170_CR337","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2018.10.023","volume":"95","author":"N Kerkar","year":"2018","unstructured":"Kerkar N, Vergani D. De novo autoimmune hepatitis- is this different in adults compared to children? J Autoimmun 2018;95:26\u201333","journal-title":"J Autoimmun"},{"key":"10170_CR338","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2015.08.017","volume":"66","author":"N Kerkar","year":"2016","unstructured":"Kerkar N, Yanni G. \u2018De novo\u2019 and \u2018recurrent\u2019 autoimmune hepatitis after liver transplantation: a comprehensive review. J Autoimmun 2016;66:17\u201324","journal-title":"J Autoimmun"},{"issue":"9","key":"10170_CR339","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/j.1478-3231.2012.02832.x","volume":"32","author":"AJ Montano-Loza","year":"2012","unstructured":"Montano-Loza AJ, Vargas-Vorackova F, Ma M, Bain VG, Burak K, Kumar T, et al. Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation. Liver Int 2012;32(9):1426\u20131433","journal-title":"Liver Int"},{"issue":"5","key":"10170_CR340","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","volume":"71","author":"P Gupta","year":"2001","unstructured":"Gupta P, Hart J, Millis JM, Cronin D, Brady L. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation 2001;71(5):664\u2013668","journal-title":"Transplantation"},{"issue":"7","key":"10170_CR341","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/lt.23422","volume":"18","author":"A Pongpaibul","year":"2012","unstructured":"Pongpaibul A, Venick RS, McDiarmid SV, Lassman CR. Histopathology of de novo autoimmune hepatitis. Liver Transpl 2012;18(7):811\u2013818","journal-title":"Liver Transpl"},{"issue":"9","key":"10170_CR342","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1007\/s10620-012-2179-3","volume":"57","author":"AJ Czaja","year":"2012","unstructured":"Czaja AJ. Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci 2012;57(9):2248\u20132266","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10170_CR343","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology 2009;50(1):291\u2013308","journal-title":"Hepatology"},{"issue":"2","key":"10170_CR344","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","volume":"44","author":"O Chazouilleres","year":"2006","unstructured":"Chazouilleres O, Wendum D, Serfaty L, Rosmorduc O, Poupon R. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 2006;44(2):400\u2013406","journal-title":"J Hepatol"},{"issue":"5","key":"10170_CR345","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.cgh.2013.09.021","volume":"12","author":"E Ozaslan","year":"2014","unstructured":"Ozaslan E, Efe C, Heurgu\u00e9-Berlot A, Kav T, Masi C, Purnak T, et al. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Clin Gastroenterol Hepatol 2014;12(5):863\u2013869","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10170_CR346","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1155\/2013\/198070","volume":"27","author":"AJ Czaja","year":"2013","unstructured":"Czaja AJ. Diagnosis and management of the overlap syndromes of autoimmune hepatitis. Can J Gastroenterol 2013;27(7):417\u2013423","journal-title":"Can J Gastroenterol"},{"issue":"7","key":"10170_CR347","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","volume":"100","author":"A Floreani","year":"2005","unstructured":"Floreani A, Rizzotto ER, Ferrara F, Carderi I, Caroli D, Blasone L, et al. Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 2005;100(7):1516\u20131522","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10170_CR348","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","volume":"28","author":"T Al-Chalabi","year":"2008","unstructured":"Al-Chalabi T, Portmann BC, Bernal W, McFarlane IG, Heneghan MA. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival. Aliment Pharmacol Ther 2008;28(2):209\u2013220","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10170_CR349","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","volume":"20","author":"R Olsson","year":"2009","unstructured":"Olsson R, Glaumann H, Almer S, Broome U, Lebrun B, Bergquist A, et al. High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis. Eur J Intern Med 2009;20(2):190\u2013196","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10170_CR350","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4254\/wjh.v6.i4.160","volume":"6","author":"A Castiella","year":"2014","unstructured":"Castiella A, Zapata E, Lucena MI, Andrade RJ. Drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease. World J Hepatol 2014;6(4):160\u2013168","journal-title":"World J Hepatol"},{"issue":"10","key":"10170_CR351","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/liv.14195","volume":"39","author":"S Weber","year":"2019","unstructured":"Weber S, Benesic A, Rotter I, Gerbes AL. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis. Liver Int 2019;39(10):1906\u20131917","journal-title":"Liver Int"},{"issue":"6","key":"10170_CR352","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/hep.23588","volume":"51","author":"E Bj\u00f6rnsson","year":"2010","unstructured":"Bj\u00f6rnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 2010;51(6):2040\u20132048","journal-title":"Hepatology"},{"issue":"4","key":"10170_CR353","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018;67(4):1560\u20131599","journal-title":"Hepatology"},{"issue":"2","key":"10170_CR354","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","volume":"69","author":"EASL","year":"2018","unstructured":"EASL. EASL recommendations on treatment of hepatitis C 2018. J Hepatol 2018;69(2):461\u2013511","journal-title":"J Hepatol"},{"issue":"9","key":"10170_CR355","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","volume":"61","author":"J De Luca-Johnson","year":"2016","unstructured":"De Luca-Johnson J, Wangensteen KJ, Hanson J, Krawitt E, Wilcox R. Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease. Dig Dis Sci 2016;61(9):2710\u20132720","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10170_CR356","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2169\/internalmedicine.8887-17","volume":"57","author":"T Komura","year":"2018","unstructured":"Komura T, Ohta H, Seike T, Shimizu Y, Nakai R, Omura H, et al. The efficacy of corticosteroid therapy in a patient with non-alcoholic steatohepatitis overlapping autoimmune hepatitis. Intern Med 2018;57(6):807\u2013812","journal-title":"Intern Med"},{"issue":"6","key":"10170_CR357","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1089\/apc.2008.0149","volume":"23","author":"DW Wan","year":"2009","unstructured":"Wan DW, Marks K, Yantiss RK, Talal AH. Autoimmune hepatitis in the HIV-infected patient: a therapeutic dilemma. AIDS Patient Care STDS 2009;23(6):407\u2013413","journal-title":"AIDS Patient Care STDS"},{"key":"10170_CR358","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","volume":"15","author":"A Tansel","year":"2017","unstructured":"Tansel A, Katz LH, El-Serag HB, Thrift AP, Parepally M, Shakhatreh MH, et al. Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2017;15(8):1207\u20131217. https:\/\/doi.org\/10.1016\/j.cgh.2017.02.006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10170_CR359","first-page":"99","volume":"92","author":"S Valean","year":"2019","unstructured":"Valean S, Acalovschi M, Dumitrascu DL, Ciobanu L, Nagy G, Chira R. Hepatocellular carcinoma in patients with autoimmune hepatitis\u2014a systematic review of the literature published between 1989\u20132016. Med Pharm Rep 2019;92(2):99\u2013105","journal-title":"Med Pharm Rep"},{"issue":"5","key":"10170_CR360","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00535-011-0519-2","volume":"47","author":"T Hino-Arinaga","year":"2012","unstructured":"Hino-Arinaga T, Ide T, Kuromatsu R, Miyajima I, Ogata K, Kuwahara R, et al. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1. J Gastroenterol 2012;47(5):569\u2013576","journal-title":"J Gastroenterol"},{"issue":"5","key":"10170_CR361","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1478-3231.2011.02734.x","volume":"32","author":"K Migita","year":"2012","unstructured":"Migita K, Watanabe Y, Jiuchi Y, Nakamura Y, Saito A, Yagura M, et al. Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese national hospital organization-autoimmune hepatitis prospective study). Liver Int 2012;32(5):837\u2013844","journal-title":"Liver Int"},{"issue":"8","key":"10170_CR362","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1111\/j.1572-0241.2008.01922.x","volume":"103","author":"AJ Montano-Loza","year":"2008","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis. Am J Gastroenterol 2008;103(8):1944\u20131951","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10170_CR363","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3748\/wjg.15.578","volume":"15","author":"A Teufel","year":"2009","unstructured":"Teufel A, Weinmann A, Centner C, Piendl A, Lohse AW, Galle PR, et al. Hepatocellular carcinoma in patients with autoimmune hepatitis. World J Gastroenterol 2009;15(5):578\u2013582","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10170_CR364","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s10620-010-1444-6","volume":"56","author":"RJ Wong","year":"2011","unstructured":"Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series. Dig Dis Sci 2011;56(2):578\u2013585","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10170_CR365","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/00365521.2014.983154","volume":"50","author":"AD Borssen","year":"2015","unstructured":"Borssen AD, Almer S, Prytz H, Wallerstedt S, Friis-Liby IL, Bergquist A, et al. Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis\u2014a long-term follow-up study in 634 Swedish patients. Scand J Gastroenterol 2015;50(2):217\u2013223","journal-title":"Scand J Gastroenterol"},{"key":"10170_CR366","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s10620-018-5441-5","volume":"64","author":"L Dakhoul","year":"2019","unstructured":"Dakhoul L, Jones KR, Gawrieh S, Ghabril M, McShane C, Vuppalanchi R, et al. Older age and disease duration are highly associated with hepatocellular carcinoma in patients with autoimmune hepatitis. Dig Dis Sci 2019;64(6):1705\u20131710. https:\/\/doi.org\/10.1007\/s10620-018-5441-5.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10170_CR367","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00535-012-0616-x","volume":"48","author":"H Ohira","year":"2013","unstructured":"Ohira H, Abe K, Takahashi A, Zeniya M, Ichida T. Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan. J Gastroenterol 2013;48(1):109\u2013114","journal-title":"J Gastroenterol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10170-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10170-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10170-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T05:23:51Z","timestamp":1675229031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10170-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":367,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10170"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10170-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}